{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:47:11Z","timestamp":1794271631827,"version":"4.9.0"},"reference-count":486,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2024-MS-077"],"award-info":[{"award-number":["2024-MS-077"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2024-BSLH-329"],"award-info":[{"award-number":["2024-BSLH-329"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2024-MS-067"],"award-info":[{"award-number":["2024-MS-067"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02764-8","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:01:51Z","timestamp":1789426911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The histone deacetylase family in health and disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Ri","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Ru","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Hui","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4954-5370","authenticated-orcid":false,"given":"Tie-Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"2764_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrg2485","volume":"10","author":"M Haberland","year":"2009","unstructured":"Haberland, M., Montgomery, R. L. & Olson, E. N. The many roles of histone deacetylases in development and physiology: Implications for disease and therapy. Nat. Rev. Genet. 10, 32\u201342 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"2764_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41580-021-00441-y","volume":"23","author":"M Shvedunova","year":"2022","unstructured":"Shvedunova, M. & Akhtar, A. Modulation of cellular processes by histone and non-histone protein acetylation. Nat. Rev. Mol. Cell Biol. 23, 329\u2013349 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2764_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41421-023-00573-9","volume":"9","author":"J Li","year":"2023","unstructured":"Li, J. et al. HDAC1\/2\/3 are major histone desuccinylases critical for promoter desuccinylation. Cell Discov. 9, 85 (2023).","journal-title":"Cell Discov."},{"key":"2764_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41421-023-00570-y","volume":"9","author":"Y He","year":"2023","unstructured":"He, Y. et al. Lysine butyrylation of HSP90 regulated by KAT8 and HDAC11 confers chemoresistance. Cell Discov. 9, 74 (2023).","journal-title":"Cell Discov."},{"key":"2764_CR5","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/cr.2017.68","volume":"27","author":"W Wei","year":"2017","unstructured":"Wei, W. et al. Class I histone deacetylases are major histone decrotonylases: evidence for critical and broad function of histone crotonylation in transcription. Cell Res. 27, 898\u2013915 (2017).","journal-title":"Cell Res"},{"key":"2764_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02651-5","volume":"9","author":"R Fellows","year":"2018","unstructured":"Fellows, R. et al. Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases. Nat. Commun. 9, 105 (2018).","journal-title":"Nat. Commun."},{"key":"2764_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/cr.2017.149","volume":"28","author":"H Huang","year":"2018","unstructured":"Huang, H. et al. Landscape of the regulatory elements for lysine 2-hydroxyisobutyrylation pathway. Cell Res. 28, 111\u2013125 (2018).","journal-title":"Cell Res"},{"key":"2764_CR8","doi-asserted-by":"publisher","first-page":"eabe2771","DOI":"10.1126\/sciadv.abe2771","volume":"7","author":"H Huang","year":"2021","unstructured":"Huang, H. et al. The regulatory enzymes and protein substrates for the lysine beta-hydroxybutyrylation pathway. Sci. Adv. 7, eabe2771 (2021).","journal-title":"Sci. Adv."},{"key":"2764_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.molcel.2016.03.036","volume":"62","author":"Z Xie","year":"2016","unstructured":"Xie, Z. et al. Metabolic regulation of gene expression by histone lysine beta-hydroxybutyrylation. Mol. Cell 62, 194\u2013206 (2016).","journal-title":"Mol. Cell"},{"key":"2764_CR10","volume":"12","author":"Z Yang","year":"2025","unstructured":"Yang, Z. et al. Lactylation of HDAC1 confers resistance to ferroptosis in colorectal cancer. Adv. Sci. (Weinh.) 12, e2408845 (2025).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"2764_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-024-03308-5","volume":"25","author":"W Fan","year":"2024","unstructured":"Fan, W. et al. A feedback loop driven by H3K9 lactylation and HDAC2 in endothelial cells regulates VEGF-induced angiogenesis. Genome Biol. 25, 165 (2024).","journal-title":"Genome Biol."},{"key":"2764_CR12","volume":"12","author":"Y Zou","year":"2025","unstructured":"Zou, Y. et al. A feedback loop driven by H4K12 Lactylation and HDAC3 in macrophages regulates lactate-induced collagen synthesis in fibroblasts via the TGF-beta signaling. Adv. Sci. (Weinh.) 12, e2411408 (2025).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"2764_CR13","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1093\/eurheartj\/ehae379","volume":"45","author":"X Li","year":"2024","unstructured":"Li, X. et al. TRAP1 drives smooth muscle cell senescence and promotes atherosclerosis via HDAC3-primed histone H4 lysine 12 lactylation. Eur. Heart J. 45, 4219\u20134235 (2024).","journal-title":"Eur. Heart J."},{"key":"2764_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52729-0","volume":"15","author":"S Sun","year":"2024","unstructured":"Sun, S. et al. Metabolic regulation of cytoskeleton functions by HDAC6-catalyzed alpha-tubulin lactylation. Nat. Commun. 15, 8377 (2024).","journal-title":"Nat. Commun."},{"key":"2764_CR15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/0006-291X(69)90661-5","volume":"36","author":"A Inoue","year":"1969","unstructured":"Inoue, A. & Fujimoto, D. Enzymatic deacetylation of histone. Biochem Biophys. Res Commun. 36, 146\u2013150 (1969).","journal-title":"Biochem Biophys. Res Commun."},{"key":"2764_CR16","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/35001622","volume":"403","author":"S Imai","year":"2000","unstructured":"Imai, S., Armstrong, C. M., Kaeberlein, M. & Guarente, L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795\u2013800 (2000).","journal-title":"Nature"},{"key":"2764_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/43710","volume":"401","author":"MS Finnin","year":"1999","unstructured":"Finnin, M. S. et al. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 401, 188\u2013193 (1999).","journal-title":"Nature"},{"key":"2764_CR18","doi-asserted-by":"publisher","first-page":"25748","DOI":"10.1074\/jbc.M111871200","volume":"277","author":"L Gao","year":"2002","unstructured":"Gao, L., Cueto, M. A., Asselbergs, F. & Atadja, P. Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J. Biol. Chem. 277, 25748\u201325755 (2002).","journal-title":"J. Biol. Chem."},{"key":"2764_CR19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1006\/bbrc.2000.3000","volume":"273","author":"RA Frye","year":"2000","unstructured":"Frye, R. A. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys. Res Commun. 273, 793\u2013798 (2000).","journal-title":"Biochem Biophys. Res Commun."},{"key":"2764_CR20","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/35106079","volume":"1","author":"P Marks","year":"2001","unstructured":"Marks, P. et al. Histone deacetylases and cancer: Causes and therapies. Nat. Rev. Cancer 1, 194\u2013202 (2001).","journal-title":"Nat. Rev. Cancer"},{"key":"2764_CR21","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1126\/science.272.5260.408","volume":"272","author":"J Taunton","year":"1996","unstructured":"Taunton, J., Hassig, C. A. & Schreiber, S. L. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272, 408\u2013411 (1996).","journal-title":"Science"},{"key":"2764_CR22","doi-asserted-by":"publisher","first-page":"12845","DOI":"10.1073\/pnas.93.23.12845","volume":"93","author":"WM Yang","year":"1996","unstructured":"Yang, W. M. et al. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc. Natl. Acad. Sci. USA 93, 12845\u201312850 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2764_CR23","doi-asserted-by":"publisher","first-page":"28001","DOI":"10.1074\/jbc.272.44.28001","volume":"272","author":"WM Yang","year":"1997","unstructured":"Yang, W. M. et al. Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family. J. Biol. Chem. 272, 28001\u201328007 (1997).","journal-title":"J. Biol. Chem."},{"key":"2764_CR24","doi-asserted-by":"publisher","first-page":"15254","DOI":"10.1074\/jbc.M908988199","volume":"275","author":"E Hu","year":"2000","unstructured":"Hu, E. et al. Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor. J. Biol. Chem. 275, 15254\u201315264 (2000).","journal-title":"J. Biol. Chem."},{"key":"2764_CR25","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1073\/pnas.96.9.4868","volume":"96","author":"CM Grozinger","year":"1999","unstructured":"Grozinger, C. M., Hassig, C. A. & Schreiber, S. L. Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc. Natl. Acad. Sci. USA 96, 4868\u20134873 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2764_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1101\/gad.14.1.55","volume":"14","author":"HY Kao","year":"2000","unstructured":"Kao, H. Y., Downes, M., Ordentlich, P. & Evans, R. M. Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev. 14, 55\u201366 (2000).","journal-title":"Genes Dev."},{"key":"2764_CR27","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1073\/pnas.97.3.1056","volume":"97","author":"X Zhou","year":"2000","unstructured":"Zhou, X., Richon, V. M., Rifkind, R. A. & Marks, P. A. Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5. Proc. Natl. Acad. Sci. USA 97, 1056\u20131061 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2764_CR28","doi-asserted-by":"publisher","first-page":"a018713","DOI":"10.1101\/cshperspect.a018713","volume":"6","author":"E Seto","year":"2014","unstructured":"Seto, E. & Yoshida, M. Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb. Perspect. Biol. 6, a018713 (2014).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2764_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1074\/jbc.M108931200","volume":"277","author":"HY Kao","year":"2002","unstructured":"Kao, H. Y. et al. Isolation and characterization of mammalian HDAC10, a novel histone deacetylase. J. Biol. Chem. 277, 187\u2013193 (2002).","journal-title":"J. Biol. Chem."},{"key":"2764_CR30","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1111\/febs.15895","volume":"289","author":"Y Nunez-Alvarez","year":"2022","unstructured":"Nunez-Alvarez, Y. & Suelves, M. HDAC11: a multifaceted histone deacetylase with proficient fatty deacylase activity and its roles in physiological processes. FEBS J. 289, 2771\u20132792 (2022).","journal-title":"FEBS J."},{"key":"2764_CR31","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/38664","volume":"389","author":"M Grunstein","year":"1997","unstructured":"Grunstein, M. Histone acetylation in chromatin structure and transcription. Nature 389, 349\u2013352 (1997).","journal-title":"Nature"},{"key":"2764_CR32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41580-018-0081-3","volume":"20","author":"T Narita","year":"2019","unstructured":"Narita, T., Weinert, B. T. & Choudhary, C. Functions and mechanisms of non-histone protein acetylation. Nat. Rev. Mol. Cell Biol. 20, 156\u2013174 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2764_CR33","doi-asserted-by":"publisher","first-page":"eaas8995","DOI":"10.1126\/science.aas8995","volume":"369","author":"VG Magupalli","year":"2020","unstructured":"Magupalli, V. G. et al. HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation. Science 369, eaas8995 (2020).","journal-title":"Science"},{"key":"2764_CR34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/nu8060381","volume":"8","author":"TX Pham","year":"2016","unstructured":"Pham, T. X., Park, Y. K. & Lee, J. Y. Anti-inflammatory effects of spirulina platensis extract via the modulation of histone deacetylases. Nutrients 8, 381 (2016).","journal-title":"Nutrients"},{"key":"2764_CR35","doi-asserted-by":"publisher","first-page":"49995","DOI":"10.1074\/jbc.M404246200","volume":"279","author":"J Wessells","year":"2004","unstructured":"Wessells, J. et al. BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages. J. Biol. Chem. 279, 49995\u201350003 (2004).","journal-title":"J. Biol. Chem."},{"key":"2764_CR36","doi-asserted-by":"publisher","first-page":"9429","DOI":"10.1074\/jbc.M109.071274","volume":"285","author":"H Zhu","year":"2010","unstructured":"Zhu, H. et al. Histone deacetylase-3 activation promotes tumor necrosis factor-alpha (TNF-alpha) expression in cardiomyocytes during lipopolysaccharide stimulation. J. Biol. Chem. 285, 9429\u20139436 (2010).","journal-title":"J. Biol. Chem."},{"key":"2764_CR37","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3858\/emm.2008.40.5.574","volume":"40","author":"Y Choi","year":"2008","unstructured":"Choi, Y. et al. Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model. Exp. Mol. Med 40, 574\u2013581 (2008).","journal-title":"Exp. Mol. Med"},{"key":"2764_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13944","volume":"8","author":"K Chakraborty","year":"2017","unstructured":"Chakraborty, K. et al. The mito-DAMP cardiolipin blocks IL-10 production causing persistent inflammation during bacterial pneumonia. Nat. Commun. 8, 13944 (2017).","journal-title":"Nat. Commun."},{"key":"2764_CR39","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/ni.1673","volume":"10","author":"A Villagra","year":"2009","unstructured":"Villagra, A. et al. The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance. Nat. Immunol. 10, 92\u2013100 (2009).","journal-title":"Nat. Immunol."},{"key":"2764_CR40","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/infdis\/jir553","volume":"204","author":"M Mombelli","year":"2011","unstructured":"Mombelli, M. et al. Histone deacetylase inhibitors impair antibacterial defenses of macrophages. J. Infect. Dis. 204, 1367\u20131374 (2011).","journal-title":"J. Infect. Dis."},{"key":"2764_CR41","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1128\/AAC.01876-15","volume":"60","author":"JK Ariffin","year":"2015","unstructured":"Ariffin, J. K. et al. Histone deacetylase inhibitors promote mitochondrial reactive oxygen species production and bacterial clearance by human macrophages. Antimicrob. Agents Chemother. 60, 1521\u20131529 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2764_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02997-2","volume":"21","author":"Q Zhou","year":"2023","unstructured":"Zhou, Q. et al. Tryptophan metabolite norharman secreted by cultivated Lactobacillus attenuates acute pancreatitis as an antagonist of histone deacetylases. BMC Med 21, 329 (2023).","journal-title":"BMC Med"},{"key":"2764_CR43","doi-asserted-by":"publisher","first-page":"4954","DOI":"10.1038\/s44318-024-00237-8","volume":"43","author":"X Li","year":"2024","unstructured":"Li, X. et al. Acetylation of TIR domains in the TLR4-Mal-MyD88 complex regulates immune responses in sepsis. EMBO J. 43, 4954\u20134983 (2024).","journal-title":"EMBO J."},{"key":"2764_CR44","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.7150\/thno.82535","volume":"13","author":"Y Zhong","year":"2023","unstructured":"Zhong, Y. et al. The HDAC10 instructs macrophage M2 program via deacetylation of STAT3 and promotes allergic airway inflammation. Theranostics 13, 3568\u20133581 (2023).","journal-title":"Theranostics"},{"key":"2764_CR45","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1158\/0008-5472.CAN-22-1270","volume":"83","author":"X Zheng","year":"2023","unstructured":"Zheng, X. et al. The HDAC2-SP1 axis orchestrates protumor macrophage polarization. Cancer Res. 83, 2345\u20132357 (2023).","journal-title":"Cancer Res"},{"key":"2764_CR46","doi-asserted-by":"publisher","first-page":"177011","DOI":"10.1016\/j.ejphar.2024.177011","volume":"983","author":"L Jin","year":"2024","unstructured":"Jin, L., Jiang, Q., Huang, H. & Zhou, X. Topical histone deacetylase inhibitor remetinostat improves IMQ-induced psoriatic dermatitis via suppressing dendritic cell maturation and keratinocyte differentiation and inflammation. Eur. J. Pharm. 983, 177011 (2024).","journal-title":"Eur. J. Pharm."},{"key":"2764_CR47","doi-asserted-by":"publisher","first-page":"eabe1935","DOI":"10.1126\/sciimmunol.abe1935","volume":"6","author":"Y Sawada","year":"2021","unstructured":"Sawada, Y. et al. Cutaneous innate immune tolerance is mediated by epigenetic control of MAP2K3 by HDAC8\/9. Sci. Immunol. 6, eabe1935 (2021).","journal-title":"Sci. Immunol."},{"key":"2764_CR48","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.kint.2024.01.010","volume":"105","author":"Y Wang","year":"2024","unstructured":"Wang, Y., Jiao, B., Hu, Z. & Wang, Y. Critical Role of histone deacetylase 3 in the regulation of kidney inflammation and fibrosis. Kidney Int. 105, 775\u2013790 (2024).","journal-title":"Kidney Int"},{"key":"2764_CR49","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13578-022-00814-6","volume":"12","author":"L Yang","year":"2022","unstructured":"Yang, L. et al. Histone deacetylase 3 facilitates TNFalpha-mediated NF-kappaB activation through suppressing CTSB induced RIP1 degradation and is required for host defense against bacterial infection. Cell Biosci. 12, 81 (2022).","journal-title":"Cell Biosci."},{"key":"2764_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1193-6","volume":"15","author":"S Chen","year":"2018","unstructured":"Chen, S. et al. Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-kappaB pathway dependent of HDAC3. J. Neuroinflamm. 15, 150 (2018).","journal-title":"J. Neuroinflamm."},{"key":"2764_CR51","doi-asserted-by":"publisher","first-page":"6141","DOI":"10.1007\/s12035-022-02965-6","volume":"59","author":"J Ye","year":"2022","unstructured":"Ye, J. et al. HDAC7 Activates IKK\/NF-kappaB signaling to regulate astrocyte-mediated inflammation. Mol. Neurobiol. 59, 6141\u20136157 (2022).","journal-title":"Mol. Neurobiol."},{"key":"2764_CR52","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.7150\/thno.65916","volume":"12","author":"G Liu","year":"2022","unstructured":"Liu, G. et al. Hepatic RACK1 deficiency protects against fulminant hepatitis through myeloid-derived suppressor cells. Theranostics 12, 2248\u20132265 (2022).","journal-title":"Theranostics"},{"key":"2764_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115693","volume":"215","author":"J Bockstiegel","year":"2023","unstructured":"Bockstiegel, J. et al. Pharmacological inhibition of HDAC6 suppresses NLRP3 inflammasome-mediated IL-1beta release. Biochem Pharm. 215, 115693 (2023).","journal-title":"Biochem Pharm."},{"key":"2764_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104799","volume":"25","author":"JD Moreira","year":"2022","unstructured":"Moreira, J. D. et al. Histone deacetylase-2 controls IL-1beta production through the regulation of NLRP3 expression and activation in tuberculosis infection. iScience 25, 104799 (2022).","journal-title":"iScience"},{"key":"2764_CR55","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022111389","volume":"42","author":"K Tsujimoto","year":"2023","unstructured":"Tsujimoto, K. et al. The lysosomal Ragulator complex activates NLRP3 inflammasome in vivo via HDAC6. EMBO J. 42, e111389 (2023).","journal-title":"EMBO J."},{"key":"2764_CR56","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.immuni.2025.01.003","volume":"58","author":"Y Asare","year":"2025","unstructured":"Asare, Y. et al. A cis-regulatory element controls expression of histone deacetylase 9 to fine-tune inflammasome-dependent chronic inflammation in atherosclerosis. Immunity 58, 555\u2013567.e559 (2025).","journal-title":"Immunity"},{"key":"2764_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01992-1","volume":"22","author":"M Yang","year":"2024","unstructured":"Yang, M. et al. HDAC10 switches NLRP3 modification from acetylation to ubiquitination and attenuates acute inflammatory diseases. Cell Commun. Signal 22, 615 (2024).","journal-title":"Cell Commun. Signal"},{"key":"2764_CR58","doi-asserted-by":"publisher","first-page":"bqae011","DOI":"10.1210\/endocr\/bqae011","volume":"165","author":"HE Byeon","year":"2024","unstructured":"Byeon, H. E. et al. HDAC11 regulates palmitate-induced NLRP3 inflammasome activation by inducing YAP expression in THP-1 cells and PBMCs. Endocrinology 165, bqae011 (2024).","journal-title":"Endocrinology"},{"key":"2764_CR59","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1136\/gut.52.1.144","volume":"52","author":"DW Hommes","year":"2003","unstructured":"Hommes, D. W., Peppelenbosch, M. P. & van Deventer, S. J. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 52, 144\u2013151 (2003).","journal-title":"Gut"},{"key":"2764_CR60","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.freeradbiomed.2016.05.014","volume":"97","author":"GS Youn","year":"2016","unstructured":"Youn, G. S., Lee, K. W., Choi, S. Y. & Park, J. Overexpression of HDAC6 induces pro-inflammatory responses by regulating ROS-MAPK-NF-kappaB\/AP-1 signaling pathways in macrophages. Free Radic. Biol. Med 97, 14\u201323 (2016).","journal-title":"Free Radic. Biol. Med"},{"key":"2764_CR61","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1007\/s10787-023-01371-1","volume":"31","author":"R Islam","year":"2023","unstructured":"Islam, R. & Singh, R. Curcumin and PCI-34051 combined treatment ameliorates inflammation and fibrosis by affecting MAP kinase pathway. Inflammopharmacology 31, 3063\u20133079 (2023).","journal-title":"Inflammopharmacology"},{"key":"2764_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03880-9","volume":"12","author":"F Zou","year":"2021","unstructured":"Zou, F. et al. Effects of short-chain fatty acids in inhibiting HDAC and activating p38 MAPK are critical for promoting B10 cell generation and function. Cell Death Dis. 12, 582 (2021).","journal-title":"Cell Death Dis."},{"key":"2764_CR63","doi-asserted-by":"crossref","unstructured":"Chandel, N. S. Carbohydrate metabolism. Cold Spring Harb. Perspect. Biol. 13, a040568 (2021).","DOI":"10.1101\/cshperspect.a040568"},{"key":"2764_CR64","doi-asserted-by":"crossref","unstructured":"Chandel, N. S. Lipid metabolism. Cold Spring Harb. Perspect. Biol. 13, a040576 (2021).","DOI":"10.1101\/cshperspect.a040576"},{"key":"2764_CR65","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00395-020-0787-1","volume":"115","author":"H Jiang","year":"2020","unstructured":"Jiang, H. et al. Exercise improves cardiac function and glucose metabolism in mice with experimental myocardial infarction through inhibiting HDAC4 and upregulating GLUT1 expression. Basic Res. Cardiol. 115, 28 (2020).","journal-title":"Basic Res. Cardiol."},{"key":"2764_CR66","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.2337\/db11-0737","volume":"61","author":"JC Weems","year":"2012","unstructured":"Weems, J. C., Griesel, B. A. & Olson, A. L. Class II histone deacetylases downregulate GLUT4 transcription in response to increased cAMP signaling in cultured adipocytes and fasting mice. Diabetes 61, 1404\u20131414 (2012).","journal-title":"Diabetes"},{"key":"2764_CR67","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1074\/jbc.M110.157107","volume":"286","author":"J Weems","year":"2011","unstructured":"Weems, J. & Olson, A. L. Class II histone deacetylases limit GLUT4 gene expression during adipocyte differentiation. J. Biol. Chem. 286, 460\u2013468 (2011).","journal-title":"J. Biol. Chem."},{"key":"2764_CR68","doi-asserted-by":"publisher","first-page":"7429","DOI":"10.1074\/jbc.M800481200","volume":"283","author":"DP Sparling","year":"2008","unstructured":"Sparling, D. P., Griesel, B. A., Weems, J. & Olson, A. L. GLUT4 enhancer factor (GEF) interacts with MEF2A and HDAC5 to regulate the GLUT4 promoter in adipocytes. J. Biol. Chem. 283, 7429\u20137437 (2008).","journal-title":"J. Biol. Chem."},{"key":"2764_CR69","doi-asserted-by":"publisher","first-page":"860","DOI":"10.2337\/db07-0843","volume":"57","author":"SL McGee","year":"2008","unstructured":"McGee, S. L. et al. AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. Diabetes 57, 860\u2013867 (2008).","journal-title":"Diabetes"},{"key":"2764_CR70","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13046-022-02305-5","volume":"41","author":"S Kwak","year":"2022","unstructured":"Kwak, S. et al. miR-3189-targeted GLUT3 repression by HDAC2 knockdown inhibits glioblastoma tumorigenesis through regulating glucose metabolism and proliferation. J. Exp. Clin. Cancer Res. 41, 87 (2022).","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"2764_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02108-z","volume":"23","author":"HT Hou","year":"2025","unstructured":"Hou, H. T. et al. Lysine 2-hydroxyisobutyrylation of HXK1 alters energy metabolism and K(ATP) channel function in the atrium from patients with atrial fibrillation. Cell Commun. Signal 23, 117 (2025).","journal-title":"Cell Commun. Signal"},{"key":"2764_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03212-3","volume":"11","author":"R Zhang","year":"2020","unstructured":"Zhang, R. et al. HDAC8-dependent deacetylation of PKM2 directs nuclear localization and glycolysis to promote proliferation in hepatocellular carcinoma. Cell Death Dis. 11, 1036 (2020).","journal-title":"Cell Death Dis."},{"key":"2764_CR73","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1158\/0008-5472.CAN-21-0763","volume":"82","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. Chromatin remodeling induced by ARID1A loss in lung cancer promotes glycolysis and confers JQ1 vulnerability. Cancer Res 82, 791\u2013804 (2022).","journal-title":"Cancer Res"},{"key":"2764_CR74","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1158\/0008-5472.CAN-20-3044","volume":"81","author":"L Bi","year":"2021","unstructured":"Bi, L. et al. HDAC11 regulates glycolysis through the LKB1\/AMPK signaling pathway to maintain hepatocellular carcinoma stemness. Cancer Res. 81, 2015\u20132028 (2021).","journal-title":"Cancer Res"},{"key":"2764_CR75","doi-asserted-by":"publisher","first-page":"eabc4897","DOI":"10.1126\/sciadv.abc4897","volume":"7","author":"CM Dowling","year":"2021","unstructured":"Dowling, C. M. et al. Multiple screening approaches reveal HDAC6 as a novel regulator of glycolytic metabolism in triple-negative breast cancer. Sci. Adv. 7, eabc4897 (2021).","journal-title":"Sci. Adv."},{"key":"2764_CR76","doi-asserted-by":"publisher","first-page":"e148438","DOI":"10.1172\/jci.insight.148438","volume":"6","author":"H Nam","year":"2021","unstructured":"Nam, H. et al. The TGF-\u03b2\/HDAC7 axis suppresses TCA cycle metabolism in renal cancer. JCI Insight 6, e148438 (2021).","journal-title":"JCI Insight"},{"key":"2764_CR77","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41420-023-01308-1","volume":"9","author":"Z Wu","year":"2023","unstructured":"Wu, Z. et al. HDAC1 disrupts the tricarboxylic acid (TCA) cycle through the deacetylation of Nur77 and promotes inflammation in ischemia-reperfusion mice. Cell Death Discov. 9, 10 (2023).","journal-title":"Cell Death Discov."},{"key":"2764_CR78","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.molcel.2014.06.020","volume":"55","author":"C Shan","year":"2014","unstructured":"Shan, C. et al. Lysine acetylation activates 6-phosphogluconate dehydrogenase to promote tumor growth. Mol. Cell 55, 552\u2013565 (2014).","journal-title":"Mol. Cell"},{"key":"2764_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1756-1","volume":"10","author":"C Shan","year":"2019","unstructured":"Shan, C. et al. 4-hydroxyphenylpyruvate dioxygenase promotes lung cancer growth via pentose phosphate pathway (PPP) flux mediated by LKB1-AMPK\/HDAC10\/G6PD axis. Cell Death Dis. 10, 525 (2019).","journal-title":"Cell Death Dis."},{"key":"2764_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101062","volume":"42","author":"O Klymenko","year":"2020","unstructured":"Klymenko, O. et al. Histone deacetylase 5 regulates interleukin 6 secretion and insulin action in skeletal muscle. Mol. Metab. 42, 101062 (2020).","journal-title":"Mol. Metab."},{"key":"2764_CR81","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bcp.2008.04.004","volume":"76","author":"C Sun","year":"2008","unstructured":"Sun, C. & Zhou, J. Trichostatin A improves insulin stimulated glucose utilization and insulin signaling transduction through the repression of HDAC2. Biochem Pharm. 76, 120\u2013127 (2008).","journal-title":"Biochem Pharm."},{"key":"2764_CR82","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.cell.2011.03.043","volume":"145","author":"MM Mihaylova","year":"2011","unstructured":"Mihaylova, M. M. et al. Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell 145, 607\u2013621 (2011).","journal-title":"Cell"},{"key":"2764_CR83","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1007\/s13238-018-0514-y","volume":"9","author":"J Li","year":"2018","unstructured":"Li, J. et al. BMAL1 functions as a cAMP-responsive coactivator of HDAC5 to regulate hepatic gluconeogenesis. Protein Cell 9, 976\u2013980 (2018).","journal-title":"Protein Cell"},{"key":"2764_CR84","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/antiox11040749","volume":"11","author":"Y Jia","year":"2022","unstructured":"Jia, Y. et al. Mechanism of action of cyanidin 3-O-glucoside in gluconeogenesis and oxidative stress-induced cancer cell senescence. Antioxid. (Basel) 11, 749 (2022).","journal-title":"Antioxid. (Basel)"},{"key":"2764_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28044-x","volume":"13","author":"A Pan","year":"2022","unstructured":"Pan, A. et al. The mitochondrial beta-oxidation enzyme HADHA restrains hepatic glucagon response by promoting beta-hydroxybutyrate production. Nat. Commun. 13, 386 (2022).","journal-title":"Nat. Commun."},{"key":"2764_CR86","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/nm.2744","volume":"18","author":"Z Sun","year":"2012","unstructured":"Sun, Z. et al. Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat. Med. 18, 934\u2013942 (2012).","journal-title":"Nat. Med."},{"key":"2764_CR87","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jcmgh.2019.10.005","volume":"9","author":"H Donde","year":"2020","unstructured":"Donde, H. et al. Tributyrin inhibits ethanol-induced epigenetic repression of CPT-1A and attenuates hepatic steatosis and injury. Cell Mol. Gastroenterol. Hepatol. 9, 569\u2013585 (2020).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"2764_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116811","volume":"317","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Erchen Decoction alleviates obesity-related hepatic steatosis via modulating gut microbiota-drived butyric acid contents and promoting fatty acid beta-oxidation. J. Ethnopharmacol. 317, 116811 (2023).","journal-title":"J. Ethnopharmacol."},{"key":"2764_CR89","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/nature07541","volume":"456","author":"T Alenghat","year":"2008","unstructured":"Alenghat, T. et al. Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology. Nature 456, 997\u20131000 (2008).","journal-title":"Nature"},{"key":"2764_CR90","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1007\/s11357-023-00849-8","volume":"45","author":"AM Elmansi","year":"2023","unstructured":"Elmansi, A. M. & Miller, R. A. Coordinated transcriptional upregulation of oxidative metabolism proteins in long-lived endocrine mutant mice. Geroscience 45, 2967\u20132981 (2023).","journal-title":"Geroscience"},{"key":"2764_CR91","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/febs.15456","volume":"288","author":"E Hurtado","year":"2021","unstructured":"Hurtado, E. et al. HDAC11 is a novel regulator of fatty acid oxidative metabolism in skeletal muscle. FEBS J. 288, 902\u2013919 (2021).","journal-title":"FEBS J."},{"key":"2764_CR92","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ebiom.2018.06.025","volume":"33","author":"L Sun","year":"2018","unstructured":"Sun, L. et al. Programming and Regulation of Metabolic Homeostasis by HDAC11. EBioMedicine 33, 157\u2013168 (2018).","journal-title":"EBioMedicine"},{"key":"2764_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05309-y","volume":"9","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. Insulin\/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis. Nat. Commun. 9, 2751 (2018).","journal-title":"Nat. Commun."},{"key":"2764_CR94","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jcmgh.2020.10.006","volume":"11","author":"L Zhang","year":"2021","unstructured":"Zhang, L. et al. S100A11 Promotes Liver Steatosis via FOXO1-Mediated Autophagy and Lipogenesis. Cell Mol. Gastroenterol. Hepatol. 11, 697\u2013724 (2021).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"2764_CR95","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41588-022-01045-8","volume":"54","author":"X Lu","year":"2022","unstructured":"Lu, X. et al. HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer. Nat. Genet 54, 670\u2013683 (2022).","journal-title":"Nat. Genet"},{"key":"2764_CR96","doi-asserted-by":"publisher","first-page":"6924","DOI":"10.1158\/0008-5472.CAN-16-1597","volume":"76","author":"HP Lin","year":"2016","unstructured":"Lin, H. P. et al. Destabilization of fatty acid synthase by acetylation inhibits de novo lipogenesis and tumor cell growth. Cancer Res. 76, 6924\u20136936 (2016).","journal-title":"Cancer Res"},{"key":"2764_CR97","doi-asserted-by":"publisher","first-page":"35457","DOI":"10.1074\/jbc.M701719200","volume":"282","author":"A Villagra","year":"2007","unstructured":"Villagra, A. et al. Histone deacetylase 3 down-regulates cholesterol synthesis through repression of lanosterol synthase gene expression. J. Biol. Chem. 282, 35457\u201335470 (2007).","journal-title":"J. Biol. Chem."},{"key":"2764_CR98","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1073\/pnas.1014890108","volume":"108","author":"NH Pipalia","year":"2011","unstructured":"Pipalia, N. H. et al. Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts. Proc. Natl. Acad. Sci. USA 108, 5620\u20135625 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2764_CR99","doi-asserted-by":"publisher","first-page":"e70978","DOI":"10.7554\/eLife.70978","volume":"10","author":"D Wilfahrt","year":"2021","unstructured":"Wilfahrt, D. et al. Histone deacetylase 3 represses cholesterol efflux during CD4(+) T-cell activation. Elife 10, e70978 (2021).","journal-title":"Elife"},{"key":"2764_CR100","doi-asserted-by":"publisher","first-page":"117070","DOI":"10.1016\/j.jep.2023.117070","volume":"319","author":"WY Deng","year":"2024","unstructured":"Deng, W. Y., Zhou, C. L. & Zeng, M. Y. Gypenoside XVII inhibits ox-LDL-induced macrophage inflammatory responses and promotes cholesterol efflux through activating the miR-182-5p\/HDAC9 signaling pathway. J. Ethnopharmacol. 319, 117070 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"2764_CR101","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1161\/ATVBAHA.114.303393","volume":"34","author":"Q Cao","year":"2014","unstructured":"Cao, Q. et al. Histone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis development. Arterioscler Thromb. Vasc. Biol. 34, 1871\u20131879 (2014).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"2764_CR102","doi-asserted-by":"publisher","first-page":"4542","DOI":"10.1158\/0008-5472.CAN-21-4362","volume":"82","author":"P Pan","year":"2022","unstructured":"Pan, P. et al. HDAC5 loss enhances phospholipid-derived arachidonic acid generation and confers sensitivity to cPLA2 inhibition in pancreatic cancer. Cancer Res. 82, 4542\u20134554 (2022).","journal-title":"Cancer Res"},{"key":"2764_CR103","volume":"2022","author":"LJ Chen","year":"2022","unstructured":"Chen, L. J. et al. ATP5O hypo-crotonylation caused by HDAC2 hyper-phosphorylation is a primary detrimental factor for downregulated phospholipid metabolism under chronic stress. Res. (Wash. D. C.) 2022, 9834963 (2022).","journal-title":"Res. (Wash. D. C.)"},{"key":"2764_CR104","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.bbrc.2014.05.016","volume":"449","author":"D Siow","year":"2014","unstructured":"Siow, D. & Wattenberg, B. The histone deacetylase-6 inhibitor tubacin directly inhibits de novo sphingolipid biosynthesis as an off-target effect. Biochem Biophys. Res. Commun. 449, 268\u2013271 (2014).","journal-title":"Biochem Biophys. Res. Commun."},{"key":"2764_CR105","volume":"9","author":"HL Zhang","year":"2022","unstructured":"Zhang, H. L. et al. Targeting mTORC2\/HDAC3 inhibits stemness of liver cancer cells against glutamine starvation. Adv. Sci. (Weinh.) 9, e2103887 (2022).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"2764_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2023.107157","volume":"149","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Histone deacetylase inhibitors synergize with sildenafil to suppress purine metabolism and proliferation in pulmonary hypertension. Vasc. Pharm. 149, 107157 (2023).","journal-title":"Vasc. Pharm."},{"key":"2764_CR107","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi, L. et al. Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 25, 486\u2013541 (2018).","journal-title":"Cell Death Differ."},{"key":"2764_CR108","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton, K., Strasser, A., Kayagaki, N. & Dixit, V. M. Cell death. Cell 187, 235\u2013256 (2024).","journal-title":"Cell"},{"key":"2764_CR109","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1161\/HYPERTENSIONAHA.121.18620","volume":"79","author":"AA Peluso","year":"2022","unstructured":"Peluso, A. A. et al. Quantitative phosphoproteomics of the angiotensin AT(2)-receptor signaling network identifies HDAC1 (histone-deacetylase-1) and p53 as mediators of antiproliferation and apoptosis. Hypertension 79, 2530\u20132541 (2022).","journal-title":"Hypertension"},{"key":"2764_CR110","doi-asserted-by":"publisher","first-page":"20436","DOI":"10.1074\/jbc.M000202200","volume":"275","author":"LJ Juan","year":"2000","unstructured":"Juan, L. J. et al. Histone deacetylases specifically down-regulate p53-dependent gene activation. J. Biol. Chem. 275, 20436\u201320443 (2000).","journal-title":"J. Biol. Chem."},{"key":"2764_CR111","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jid.2021.05.026","volume":"142","author":"X Zhu","year":"2022","unstructured":"Zhu, X. et al. HDAC1\/2 control proliferation and survival in adult epidermis and pre\u2012basal cell carcinoma through p16 and p53. J. Invest Dermatol 142, 77\u201387.e10 (2022).","journal-title":"J. Invest Dermatol"},{"key":"2764_CR112","doi-asserted-by":"publisher","first-page":"e91316","DOI":"10.1172\/jci.insight.91316","volume":"3","author":"K Kanda","year":"2018","unstructured":"Kanda, K. et al. Nardilysin controls intestinal tumorigenesis through HDAC1\/p53-dependent transcriptional regulation. JCI Insight 3, e91316 (2018).","journal-title":"JCI Insight"},{"key":"2764_CR113","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1158\/0008-5472.CAN-06-4397","volume":"67","author":"KL Harms","year":"2007","unstructured":"Harms, K. L. & Chen, X. Histone deacetylase 2 modulates p53 transcriptional activities through regulation of p53-DNA binding activity. Cancer Res. 67, 3145\u20133152 (2007).","journal-title":"Cancer Res"},{"key":"2764_CR114","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/jmcb\/mjs013","volume":"4","author":"A Brandl","year":"2012","unstructured":"Brandl, A. et al. Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress. J. Mol. Cell Biol. 4, 284\u2013293 (2012).","journal-title":"J. Mol. Cell Biol."},{"key":"2764_CR115","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-03027-6","volume":"19","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q. et al. Dexmedetomidine inhibits mitochondria damage and apoptosis of enteric glial cells in experimental intestinal ischemia\/reperfusion injury via SIRT3-dependent PINK1\/HDAC3\/p53 pathway. J. Transl. Med 19, 463 (2021).","journal-title":"J. Transl. Med"},{"key":"2764_CR116","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1182\/blood-2017-03-771386","volume":"130","author":"WK Hua","year":"2017","unstructured":"Hua, W. K. et al. HDAC8 regulates long-term hematopoietic stem-cell maintenance under stress by modulating p53 activity. Blood 130, 2619\u20132630 (2017).","journal-title":"Blood"},{"key":"2764_CR117","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.stem.2015.08.004","volume":"17","author":"J Qi","year":"2015","unstructured":"Qi, J. et al. HDAC8 inhibition specifically targets Inv(16) acute myeloid leukemic stem cells by restoring p53 acetylation. Cell Stem Cell 17, 597\u2013610 (2015).","journal-title":"Cell Stem Cell"},{"key":"2764_CR118","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.canlet.2017.01.033","volume":"391","author":"HW Ryu","year":"2017","unstructured":"Ryu, H. W. et al. HDAC6 deacetylates p53 at lysines 381\/382 and differentially coordinates p53-induced apoptosis. Cancer Lett. 391, 162\u2013171 (2017).","journal-title":"Cancer Lett."},{"key":"2764_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.127","volume":"4","author":"T Ozaki","year":"2013","unstructured":"Ozaki, T. et al. Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage. Cell Death Dis. 4, e610 (2013).","journal-title":"Cell Death Dis."},{"key":"2764_CR120","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.molcel.2013.09.003","volume":"52","author":"N Sen","year":"2013","unstructured":"Sen, N., Kumari, R., Singh, M. I. & Das, S. HDAC5, a key component in temporal regulation of p53-mediated transactivation in response to genotoxic stress. Mol. Cell 52, 406\u2013420 (2013).","journal-title":"Mol. Cell"},{"key":"2764_CR121","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1523\/JNEUROSCI.2444-14.2015","volume":"35","author":"S Peng","year":"2015","unstructured":"Peng, S. et al. HDAC2 selectively regulates FOXO3a-mediated gene transcription during oxidative stress-induced neuronal cell death. J. Neurosci. 35, 1250\u20131259 (2015).","journal-title":"J. Neurosci."},{"key":"2764_CR122","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1593\/neo.81358","volume":"11","author":"Y Yang","year":"2009","unstructured":"Yang, Y. et al. Acetylation of FoxO1 activates Bim expression to induce apoptosis in response to histone deacetylase inhibitor depsipeptide treatment. Neoplasia 11, 313\u2013324 (2009).","journal-title":"Neoplasia"},{"key":"2764_CR123","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/cdd.2011.51","volume":"18","author":"G Shu","year":"2011","unstructured":"Shu, G. et al. Zac1 is a histone acetylation-regulated NF-kappaB suppressor that mediates histone deacetylase inhibitor-induced apoptosis. Cell Death Differ. 18, 1825\u20131835 (2011).","journal-title":"Cell Death Differ."},{"key":"2764_CR124","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1007\/s12975-024-01272-7","volume":"16","author":"H Lin","year":"2025","unstructured":"Lin, H. et al. HDAC9 deficiency upregulates cGMP-dependent kinase II to mitigate neuronal apoptosis in ischemic stroke. Transl. Stroke Res. 16, 868\u2013881 (2025).","journal-title":"Transl. Stroke Res"},{"key":"2764_CR125","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/s41418-019-0480-9","volume":"27","author":"Y Yang","year":"2020","unstructured":"Yang, Y. & Klionsky, D. J. Autophagy and disease: Unanswered questions. Cell Death Differ. 27, 858\u2013871 (2020).","journal-title":"Cell Death Differ."},{"key":"2764_CR126","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/emboj\/cdg115","volume":"22","author":"Y Zhang","year":"2003","unstructured":"Zhang, Y. et al. HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. EMBO J. 22, 1168\u20131179 (2003).","journal-title":"EMBO J."},{"key":"2764_CR127","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/417455a","volume":"417","author":"C Hubbert","year":"2002","unstructured":"Hubbert, C. et al. HDAC6 is a microtubule-associated deacetylase. Nature 417, 455\u2013458 (2002).","journal-title":"Nature"},{"key":"2764_CR128","doi-asserted-by":"publisher","first-page":"E5178","DOI":"10.1073\/pnas.1415589111","volume":"111","author":"PM McLendon","year":"2014","unstructured":"McLendon, P. M. et al. Tubulin hyperacetylation is adaptive in cardiac proteotoxicity by promoting autophagy. Proc. Natl. Acad. Sci. USA 111, E5178\u2013E5186 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2764_CR129","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s13287-019-1441-4","volume":"10","author":"Z Li","year":"2019","unstructured":"Li, Z. et al. Microtubule destabilization caused by silicate via HDAC6 activation contributes to autophagic dysfunction in bone mesenchymal stem cells. Stem Cell Res.Ther. 10, 351 (2019).","journal-title":"Stem Cell Res.Ther."},{"key":"2764_CR130","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1083\/jcb.201804165","volume":"218","author":"R Wang","year":"2019","unstructured":"Wang, R. et al. ATP13A2 facilitates HDAC6 recruitment to lysosome to promote autophagosome-lysosome fusion. J. Cell Biol. 218, 267\u2013284 (2019).","journal-title":"J. Cell Biol."},{"key":"2764_CR131","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1080\/15548627.2024.2431472","volume":"21","author":"Q Liu","year":"2025","unstructured":"Liu, Q. et al. Upregulation of ISG15 induced by MAPT\/tau accumulation represses autophagic flux by inhibiting HDAC6 activity: A vicious cycle in Alzheimer disease. Autophagy 21, 807\u2013826 (2025).","journal-title":"Autophagy"},{"key":"2764_CR132","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fphar.2018.00034","volume":"9","author":"AS Brijmohan","year":"2018","unstructured":"Brijmohan, A. S. et al. HDAC6 Inhibition Promotes Transcription Factor EB activation and is protective in experimental kidney disease. Front Pharm. 9, 34 (2018).","journal-title":"Front Pharm."},{"key":"2764_CR133","doi-asserted-by":"publisher","first-page":"13425","DOI":"10.1073\/pnas.172511699","volume":"99","author":"SS Hook","year":"2002","unstructured":"Hook, S. S., Orian, A., Cowley, S. M. & Eisenman, R. N. Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes. Proc. Natl. Acad. Sci. USA 99, 13425\u201313430 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2764_CR134","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s11658-016-0031-z","volume":"21","author":"WJ Liu","year":"2016","unstructured":"Liu, W. J. et al. p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation. Cell Mol. Biol. Lett. 21, 29 (2016).","journal-title":"Cell Mol. Biol. Lett."},{"key":"2764_CR135","doi-asserted-by":"publisher","first-page":"4672","DOI":"10.1111\/febs.13540","volume":"282","author":"Y Katsuragi","year":"2015","unstructured":"Katsuragi, Y., Ichimura, Y. & Komatsu, M. p62\/SQSTM1 functions as a signaling hub and an autophagy adaptor. FEBS J. 282, 4672\u20134678 (2015).","journal-title":"FEBS J."},{"key":"2764_CR136","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0092-8674(03)00939-5","volume":"115","author":"Y Kawaguchi","year":"2003","unstructured":"Kawaguchi, Y. et al. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115, 727\u2013738 (2003).","journal-title":"Cell"},{"key":"2764_CR137","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nature05853","volume":"447","author":"UB Pandey","year":"2007","unstructured":"Pandey, U. B. et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447, 859\u2013863 (2007).","journal-title":"Nature"},{"key":"2764_CR138","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1083\/jcb.201001039","volume":"189","author":"JY Lee","year":"2010","unstructured":"Lee, J. Y. et al. Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy. J. Cell Biol. 189, 671\u2013679 (2010).","journal-title":"J. Cell Biol."},{"key":"2764_CR139","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1039\/D4FO01027B","volume":"15","author":"L Fan","year":"2024","unstructured":"Fan, L. et al. Hydroxytyrosol ameliorates stress-induced liver injury through activating autophagy via HDAC1\/2 inhibition. Food Funct. 15, 5103\u20135117 (2024).","journal-title":"Food Funct."},{"key":"2764_CR140","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1111\/febs.15122","volume":"287","author":"J Sun","year":"2020","unstructured":"Sun, J. et al. Valproic acid targets HDAC1\/2 and HDAC1\/PTEN\/Akt signalling to inhibit cell proliferation via the induction of autophagy in gastric cancer. FEBS J. 287, 2118\u20132133 (2020).","journal-title":"FEBS J."},{"key":"2764_CR141","doi-asserted-by":"publisher","first-page":"8008","DOI":"10.1096\/fj.201900127R","volume":"33","author":"W Du","year":"2019","unstructured":"Du, W. et al. STAT3 phosphorylation mediates high glucose-impaired cell autophagy in an HDAC1-dependent and -independent manner in Schwann cells of diabetic peripheral neuropathy. FASEB J. 33, 8008\u20138021 (2019).","journal-title":"FASEB J."},{"key":"2764_CR142","doi-asserted-by":"publisher","first-page":"e00036","DOI":"10.1128\/mSphere.00036-21","volume":"6","author":"A Madhavan","year":"2021","unstructured":"Madhavan, A. et al. Transcription repressor protein ZBTB25 associates with HDAC1-Sin3a complex in mycobacterium tuberculosis-infected macrophages, and its inhibition clears pathogen by autophagy. mSphere 6, e00036\u201321 (2021).","journal-title":"mSphere"},{"key":"2764_CR143","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1073\/pnas.1121159109","volume":"109","author":"V Moresi","year":"2012","unstructured":"Moresi, V. et al. Histone deacetylases 1 and 2 regulate autophagy flux and skeletal muscle homeostasis in mice. Proc. Natl. Acad. Sci. USA 109, 1649\u20131654 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2764_CR144","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.yjmcc.2018.04.009","volume":"119","author":"S Wang","year":"2018","unstructured":"Wang, S. et al. Ablation of toll-like receptor 4 attenuates aging-induced myocardial remodeling and contractile dysfunction through NCoRI-HDAC1-mediated regulation of autophagy. J. Mol. Cell Cardiol. 119, 40\u201350 (2018).","journal-title":"J. Mol. Cell Cardiol."},{"key":"2764_CR145","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1080\/15548627.2020.1725376","volume":"17","author":"W Wu","year":"2021","unstructured":"Wu, W. et al. Cholesterol derivatives induce dephosphorylation of the histone deacetylases Rpd3\/HDAC1 to upregulate autophagy. Autophagy 17, 512\u2013528 (2021).","journal-title":"Autophagy"},{"key":"2764_CR146","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41416-022-01805-7","volume":"127","author":"WJ Zang","year":"2022","unstructured":"Zang, W. J. et al. HDAC4 promotes the growth and metastasis of gastric cancer via autophagic degradation of MEKK3. Br. J. Cancer 127, 237\u2013248 (2022).","journal-title":"Br. J. Cancer"},{"key":"2764_CR147","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/15548627.2019.1635380","volume":"16","author":"H Wu","year":"2020","unstructured":"Wu, H. et al. MIR145-3p promotes autophagy and enhances bortezomib sensitivity in multiple myeloma by targeting HDAC4. Autophagy 16, 683\u2013697 (2020).","journal-title":"Autophagy"},{"key":"2764_CR148","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/ptr.8059","volume":"38","author":"Z Zuo","year":"2024","unstructured":"Zuo, Z. et al. Berberine ameliorates contrast-induced acute kidney injury by regulating HDAC4-FoxO3a axis-induced autophagy: In vivo and in vitro. Phytother. Res. 38, 1761\u20131780 (2024).","journal-title":"Phytother. Res"},{"key":"2764_CR149","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/ki.2014.111","volume":"86","author":"X Wang","year":"2014","unstructured":"Wang, X. et al. Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy. Kidney Int. 86, 712\u2013725 (2014).","journal-title":"Kidney Int."},{"key":"2764_CR150","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/cvr\/cvy051","volume":"114","author":"D Yang","year":"2018","unstructured":"Yang, D. et al. HDAC4 regulates vascular inflammation via activation of autophagy. Cardiovasc Res. 114, 1016\u20131028 (2018).","journal-title":"Cardiovasc Res"},{"key":"2764_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110873","volume":"111","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. CX3CL1 represses autophagy via CX3CR1\/ CaMKIIdelta\/HDAC4\/Rubicon axis and exacerbates chronic intermittent hypoxia induced Kupffer cell apoptosis. Cell Signal 111, 110873 (2023).","journal-title":"Cell Signal"},{"key":"2764_CR152","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.7150\/thno.29673","volume":"9","author":"X Zhang","year":"2019","unstructured":"Zhang, X., Qi, Z., Yin, H. & Yang, G. Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1alpha-mediated regulation of apoptosis and autophagy. Theranostics 9, 1096\u20131114 (2019).","journal-title":"Theranostics"},{"key":"2764_CR153","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301429R","volume":"38","author":"G Zhou","year":"2024","unstructured":"Zhou, G. et al. HDAC2 counteracts vascular calcification by activating autophagy in chronic kidney disease. FASEB J. 38, e23470 (2024).","journal-title":"FASEB J."},{"key":"2764_CR154","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1080\/15548627.2024.2323785","volume":"20","author":"JH Cho","year":"2024","unstructured":"Cho, J. H. et al. Sodium butyrate ameliorates high glucose-suppressed neuronal mitophagy by restoring PRKN expression via inhibiting the RELA-HDAC8 complex. Autophagy 20, 1505\u20131522 (2024).","journal-title":"Autophagy"},{"key":"2764_CR155","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1763-2","volume":"10","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z. et al. Increase in HDAC9 suppresses myoblast differentiation via epigenetic regulation of autophagy in hypoxia. Cell Death Dis. 10, 552 (2019).","journal-title":"Cell Death Dis."},{"key":"2764_CR156","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jnutbio.2015.08.031","volume":"27","author":"G Pinto","year":"2016","unstructured":"Pinto, G., Shtaif, B., Phillip, M. & Gat-Yablonski, G. Growth attenuation is associated with histone deacetylase 10-induced autophagy in the liver. J. Nutr. Biochem 27, 171\u2013180 (2016).","journal-title":"J. Nutr. Biochem"},{"key":"2764_CR157","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.4161\/auto.26450","volume":"9","author":"I Oehme","year":"2013","unstructured":"Oehme, I., Lodrini, M., Brady, N. R. & Witt, O. Histone deacetylase 10-promoted autophagy as a druggable point of interference to improve the treatment response of advanced neuroblastomas. Autophagy 9, 2163\u20132165 (2013).","journal-title":"Autophagy"},{"key":"2764_CR158","doi-asserted-by":"publisher","first-page":"E2592","DOI":"10.1073\/pnas.1300113110","volume":"110","author":"I Oehme","year":"2013","unstructured":"Oehme, I. et al. Histone deacetylase 10 promotes autophagy-mediated cell survival. Proc. Natl. Acad. Sci. USA 110, E2592\u2013E2601 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2764_CR159","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon, S. J. & Olzmann, J. A. The cell biology of ferroptosis. Nat. Rev. Mol. Cell Biol. 25, 424\u2013442 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2764_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102939","volume":"68","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. HDAC3 aberration-incurred GPX4 suppression drives renal ferroptosis and AKI-CKD progression. Redox Biol. 68, 102939 (2023).","journal-title":"Redox Biol."},{"key":"2764_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217726","volume":"623","author":"H Zhang","year":"2025","unstructured":"Zhang, H. et al. SIK1 promotes ferroptosis resistance in pancreatic cancer via HDAC5-STAT6-SLC7A11 axis. Cancer Lett. 623, 217726 (2025).","journal-title":"Cancer Lett."},{"key":"2764_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07477-4","volume":"16","author":"P Zhou","year":"2025","unstructured":"Zhou, P. et al. HAT1\/HDAC2 mediated ACSL4 acetylation confers radiosensitivity by inducing ferroptosis in nasopharyngeal carcinoma. Cell Death Dis. 16, 160 (2025).","journal-title":"Cell Death Dis."},{"key":"2764_CR163","volume":"6","author":"H Meng","year":"2023","unstructured":"Meng, H. et al. Hepatic HDAC3 regulates systemic iron homeostasis and ferroptosis via the hippo signaling pathway. Res. (Wash. D. C.) 6, 0281 (2023).","journal-title":"Res. (Wash. D. C.)"},{"key":"2764_CR164","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot, D., Latz, E. & Franklin, B. S. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol. Immunol. 18, 1106\u20131121 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"2764_CR165","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1182\/blood.2025028938","volume":"146","author":"A Saorin","year":"2025","unstructured":"Saorin, A. et al. Transcriptional remodeling shapes therapeutic vulnerability to necroptosis in acute lymphoblastic leukemia. Blood 146, 861\u2013873 (2025).","journal-title":"Blood"},{"key":"2764_CR166","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.canlet.2015.05.020","volume":"366","author":"S Steinwascher","year":"2015","unstructured":"Steinwascher, S., Nugues, A. L., Schoeneberger, H. & Fulda, S. Identification of a novel synergistic induction of cell death by Smac mimetic and HDAC inhibitors in acute myeloid leukemia cells. Cancer Lett. 366, 32\u201343 (2015).","journal-title":"Cancer Lett."},{"key":"2764_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103256","volume":"24","author":"V Poli","year":"2021","unstructured":"Poli, V. et al. Zinc-dependent histone deacetylases drive neutrophil extracellular trap formation and potentiate local and systemic inflammation. iScience 24, 103256 (2021).","journal-title":"iScience"},{"key":"2764_CR168","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1111\/bph.16299","volume":"181","author":"C Xu","year":"2024","unstructured":"Xu, C. et al. Histone deacetylase-mediated silencing of PSTPIP2 expression contributes to aristolochic acid nephropathy-induced PANoptosis. Br. J. Pharm. 181, 1452\u20131473 (2024).","journal-title":"Br. J. Pharm."},{"key":"2764_CR169","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41421-025-00804-1","volume":"11","author":"J Lin","year":"2025","unstructured":"Lin, J. et al. NUDT21 lactylation reprograms alternative polyadenylation to promote cuproptosis resistance. Cell Discov. 11, 52 (2025).","journal-title":"Cell Discov."},{"key":"2764_CR170","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","volume":"86","author":"H Sies","year":"2017","unstructured":"Sies, H., Berndt, C. & Jones, D. P. Oxidative Stress. Annu Rev. Biochem 86, 715\u2013748 (2017).","journal-title":"Annu Rev. Biochem"},{"key":"2764_CR171","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jare.2024.10.037","volume":"75","author":"Z Yue","year":"2025","unstructured":"Yue, Z. et al. Kaempferol alleviates myocardial ischemia injury by reducing oxidative stress via the HDAC3-mediated Nrf2 signaling pathway. J. Adv. Res. 75, 755\u2013764 (2025).","journal-title":"J. Adv. Res"},{"key":"2764_CR172","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkad062","volume":"12","author":"L Xu","year":"2024","unstructured":"Xu, L. et al. Histone deacetylase 3-specific inhibitor RGFP966 attenuates oxidative stress and inflammation after traumatic brain injury by activating the Nrf2 pathway. Burns Trauma 12, tkad062 (2024).","journal-title":"Burns Trauma"},{"key":"2764_CR173","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201948375","volume":"20","author":"AM El-Naggar","year":"2019","unstructured":"El-Naggar, A. M. et al. Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasis. EMBO Rep. 20, e48375 (2019).","journal-title":"EMBO Rep."},{"key":"2764_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156205","volume":"135","author":"Q Ma","year":"2024","unstructured":"Ma, Q. et al. Damascenone inhibits osteoclastogenesis by epigenetically modulating Nrf2-mediated ROS scavenge and counteracts OVX-induced osteoporosis. Phytomedicine 135, 156205 (2024).","journal-title":"Phytomedicine"},{"key":"2764_CR175","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1126\/science.1227166","volume":"339","author":"T Shimazu","year":"2013","unstructured":"Shimazu, T. et al. Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339, 211\u2013214 (2013).","journal-title":"Science"},{"key":"2764_CR176","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1089\/neu.2017.5192","volume":"34","author":"G Kong","year":"2017","unstructured":"Kong, G. et al. The Ketone Metabolite beta-Hydroxybutyrate Attenuates Oxidative Stress in Spinal Cord Injury by Suppression of Class I Histone Deacetylases. J. Neurotrauma 34, 2645\u20132655 (2017).","journal-title":"J. Neurotrauma"},{"key":"2764_CR177","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s00018-022-04341-y","volume":"79","author":"M Wang","year":"2022","unstructured":"Wang, M. et al. Upregulation of MDH1 acetylation by HDAC6 inhibition protects against oxidative stress-derived neuronal apoptosis following intracerebral hemorrhage. Cell Mol. Life Sci. 79, 356 (2022).","journal-title":"Cell Mol. Life Sci."},{"key":"2764_CR178","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111350","volume":"127","author":"Y Ou","year":"2024","unstructured":"Ou, Y. et al. TDP43\/HDAC6\/Prdx1 signaling pathway participated in the cognitive impairment of obstructive sleep apnea via regulating inflammation and oxidative stress. Int Immunopharmacol. 127, 111350 (2024).","journal-title":"Int Immunopharmacol."},{"key":"2764_CR179","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.415","volume":"8","author":"J Leyk","year":"2017","unstructured":"Leyk, J. et al. HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness. Cell Death Dis. 8, e3028 (2017).","journal-title":"Cell Death Dis."},{"key":"2764_CR180","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1111\/febs.70026","volume":"292","author":"Z Chi","year":"2025","unstructured":"Chi, Z. et al. HDAC6 inhibition upregulates endothelial SOD3 expression via Sp1 acetylation and attenuates angiotensin II-induced hypertension. FEBS J. 292, 2624\u20132644 (2025).","journal-title":"FEBS J."},{"key":"2764_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101338","volume":"28","author":"SA Manea","year":"2020","unstructured":"Manea, S. A. et al. Pharmacological inhibition of histone deacetylase reduces NADPH oxidase expression, oxidative stress and the progression of atherosclerotic lesions in hypercholesterolemic apolipoprotein E-deficient mice; potential implications for human atherosclerosis. Redox Biol. 28, 101338 (2020).","journal-title":"Redox Biol."},{"key":"2764_CR182","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41556-022-00860-9","volume":"24","author":"G Gaglia","year":"2022","unstructured":"Gaglia, G. et al. Temporal and spatial topography of cell proliferation in cancer. Nat. Cell Biol. 24, 316\u2013326 (2022).","journal-title":"Nat. Cell Biol."},{"key":"2764_CR183","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.stem.2021.07.002","volume":"28","author":"L Cordero-Espinoza","year":"2021","unstructured":"Cordero-Espinoza, L. et al. Dynamic cell contacts between periportal mesenchyme and ductal epithelium act as a rheostat for liver cell proliferation. Cell Stem Cell 28, 1907\u20131921.e1908 (2021).","journal-title":"Cell Stem Cell"},{"key":"2764_CR184","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jhep.2020.10.021","volume":"74","author":"J Wang","year":"2021","unstructured":"Wang, J. et al. Tumor-derived adenosine promotes macrophage proliferation in human hepatocellular carcinoma. J. Hepatol. 74, 627\u2013637 (2021).","journal-title":"J. Hepatol."},{"key":"2764_CR185","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.jcmgh.2021.06.026","volume":"12","author":"M Rivas","year":"2021","unstructured":"Rivas, M. et al. HDAC1-Dependent Repression of Markers of Hepatocytes and P21 Is Involved in Development of Pediatric Liver Cancer. Cell Mol. Gastroenterol. Hepatol. 12, 1669\u20131682 (2021).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"2764_CR186","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s13018-022-03224-z","volume":"17","author":"Y Zeng","year":"2022","unstructured":"Zeng, Y. et al. HDAC1 regulates inflammation and osteogenic differentiation of ankylosing spondylitis fibroblasts through the Wnt-Smad signaling pathway. J. Orthop. Surg. Res. 17, 343 (2022).","journal-title":"J. Orthop. Surg. Res"},{"key":"2764_CR187","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.apsb.2021.07.003","volume":"12","author":"X Sun","year":"2022","unstructured":"Sun, X. et al. Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy. Acta Pharm. Sin. B 12, 838\u2013852 (2022).","journal-title":"Acta Pharm. Sin. B"},{"key":"2764_CR188","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ejps.2018.08.030","volume":"124","author":"P Trivedi","year":"2018","unstructured":"Trivedi, P. et al. Design, synthesis and biological screening of 2-aminobenzamides as selective HDAC3 inhibitors with promising anticancer effects. Eur. J. Pharm. Sci. 124, 165\u2013181 (2018).","journal-title":"Eur. J. Pharm. Sci."},{"key":"2764_CR189","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3632549","volume":"2022","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Chidamide suppresses the growth of cholangiocarcinoma by inhibiting HDAC3 and promoting FOXO1 acetylation. Stem Cells Int 2022, 3632549 (2022).","journal-title":"Stem Cells Int"},{"key":"2764_CR190","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s13402-019-00439-x","volume":"43","author":"S Yu","year":"2020","unstructured":"Yu, S. et al. Endocrine resistant breast cancer cells with loss of ERalpha expression retain proliferative ability by reducing caspase7-mediated HDAC3 cleavage. Cell Oncol. (Dordr.) 43, 65\u201380 (2020).","journal-title":"Cell Oncol. (Dordr.)"},{"key":"2764_CR191","doi-asserted-by":"publisher","first-page":"117028","DOI":"10.1016\/j.bmc.2022.117028","volume":"73","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. Identification of PI3K\/HDAC Dual-targeted inhibitors with subtype selectivity as potential therapeutic agents against solid Tumors: Building HDAC6 potency in a Quinazolinone-based PI3Kdelta-selective template. Bioorg. Med Chem. 73, 117028 (2022).","journal-title":"Bioorg. Med Chem."},{"key":"2764_CR192","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jare.2022.06.009","volume":"46","author":"TY Wu","year":"2023","unstructured":"Wu, T. Y. et al. Rational design of synthetically tractable HDAC6\/HSP90 dual inhibitors to destroy immune-suppressive tumor microenvironment. J. Adv. Res. 46, 159\u2013171 (2023).","journal-title":"J. Adv. Res"},{"key":"2764_CR193","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.24","volume":"6","author":"I Rettig","year":"2015","unstructured":"Rettig, I. et al. Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation. Cell Death Dis. 6, e1657 (2015).","journal-title":"Cell Death Dis."},{"key":"2764_CR194","doi-asserted-by":"publisher","first-page":"6607","DOI":"10.1074\/jbc.M114.600627","volume":"290","author":"RK Singh","year":"2015","unstructured":"Singh, R. K. et al. Mechanism of N-Acylthiourea-mediated activation of human histone deacetylase 8 (HDAC8) at molecular and cellular levels. J. Biol. Chem. 290, 6607\u20136619 (2015).","journal-title":"J. Biol. Chem."},{"key":"2764_CR195","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.106112","volume":"128","author":"H Tang","year":"2022","unstructured":"Tang, H. et al. Discovery of a 2,6-diarylpyridine-based hydroxamic acid derivative as novel histone deacetylase 8 and tubulin dual inhibitor for the treatment of neuroblastoma. Bioorg. Chem. 128, 106112 (2022).","journal-title":"Bioorg. Chem."},{"key":"2764_CR196","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ejmech.2018.03.002","volume":"150","author":"C Zhao","year":"2018","unstructured":"Zhao, C. et al. Discovery of meta-sulfamoyl N-hydroxybenzamides as HDAC8 selective inhibitors. Eur. J. Med. Chem. 150, 282\u2013291 (2018).","journal-title":"Eur. J. Med. Chem."},{"key":"2764_CR197","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0301-8","volume":"51","author":"K Xiong","year":"2019","unstructured":"Xiong, K. et al. Identification of HDAC9 as a viable therapeutic target for the treatment of gastric cancer. Exp. Mol. Med. 51, 1\u201315 (2019).","journal-title":"Exp. Mol. Med"},{"key":"2764_CR198","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176483","volume":"970","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Activation of CaMKII\/HDAC4 by SDF1 contributes to pulmonary arterial hypertension via stabilization Runx2. Eur. J. Pharm. 970, 176483 (2024).","journal-title":"Eur. J. Pharm."},{"key":"2764_CR199","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2521-1","volume":"11","author":"QG Li","year":"2020","unstructured":"Li, Q. G. et al. HDAC7 promotes the oncogenicity of nasopharyngeal carcinoma cells by miR-4465-EphA2 signaling axis. Cell Death Dis. 11, 322 (2020).","journal-title":"Cell Death Dis."},{"key":"2764_CR200","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1161\/CIRCRESAHA.109.213165","volume":"106","author":"A Margariti","year":"2010","unstructured":"Margariti, A. et al. Histone deacetylase 7 controls endothelial cell growth through modulation of beta-catenin. Circ. Res. 106, 1202\u20131211 (2010).","journal-title":"Circ. Res."},{"key":"2764_CR201","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1126\/science.1092053","volume":"302","author":"AJ Ridley","year":"2003","unstructured":"Ridley, A. J. et al. Cell migration: Integrating signals from front to back. Science 302, 1704\u20131709 (2003).","journal-title":"Science"},{"key":"2764_CR202","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.tcb.2020.06.004","volume":"30","author":"S Seetharaman","year":"2020","unstructured":"Seetharaman, S. & Etienne-Manneville, S. Cytoskeletal crosstalk in cell migration. Trends Cell Biol. 30, 720\u2013735 (2020).","journal-title":"Trends Cell Biol."},{"key":"2764_CR203","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.tcb.2008.04.003","volume":"18","author":"A Valenzuela-Fernandez","year":"2008","unstructured":"Valenzuela-Fernandez, A., Cabrero, J. R., Serrador, J. M. & Sanchez-Madrid, F. HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions. Trends Cell Biol. 18, 291\u2013297 (2008).","journal-title":"Trends Cell Biol."},{"key":"2764_CR204","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.201403039","volume":"206","author":"NO Deakin","year":"2014","unstructured":"Deakin, N. O. & Turner, C. E. Paxillin inhibits HDAC6 to regulate microtubule acetylation, Golgi structure, and polarized migration. J. Cell Biol. 206, 395\u2013413 (2014).","journal-title":"J. Cell Biol."},{"key":"2764_CR205","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1182\/blood-2011-04-350025","volume":"119","author":"GM Birdsey","year":"2012","unstructured":"Birdsey, G. M. et al. The transcription factor Erg regulates expression of histone deacetylase 6 and multiple pathways involved in endothelial cell migration and angiogenesis. Blood 119, 894\u2013903 (2012).","journal-title":"Blood"},{"key":"2764_CR206","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105076","volume":"160","author":"M Dawood","year":"2020","unstructured":"Dawood, M. et al. Inhibition of cell migration and induction of apoptosis by a novel class II histone deacetylase inhibitor, MCC2344. Pharm. Res. 160, 105076 (2020).","journal-title":"Pharm. Res"},{"key":"2764_CR207","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.molcel.2007.05.033","volume":"27","author":"X Zhang","year":"2007","unstructured":"Zhang, X. et al. HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol. Cell 27, 197\u2013213 (2007).","journal-title":"Mol. Cell"},{"key":"2764_CR208","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.1038\/emboj.2011.298","volume":"30","author":"D Kaluza","year":"2011","unstructured":"Kaluza, D. et al. Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin. EMBO J. 30, 4142\u20134156 (2011).","journal-title":"EMBO J."},{"key":"2764_CR209","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41388-020-01550-2","volume":"40","author":"TQ Pham","year":"2021","unstructured":"Pham, T. Q. et al. HDAC6 promotes growth, migration\/invasion, and self-renewal of rhabdomyosarcoma. Oncogene 40, 578\u2013591 (2021).","journal-title":"Oncogene"},{"key":"2764_CR210","doi-asserted-by":"publisher","first-page":"33156","DOI":"10.1074\/jbc.M113.472506","volume":"288","author":"KA Williams","year":"2013","unstructured":"Williams, K. A. et al. Extracellular signal-regulated kinase (ERK) phosphorylates histone deacetylase 6 (HDAC6) at serine 1035 to stimulate cell migration. J. Biol. Chem. 288, 33156\u201333170 (2013).","journal-title":"J. Biol. Chem."},{"key":"2764_CR211","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06656-z","volume":"15","author":"Y Yang","year":"2024","unstructured":"Yang, Y. et al. GATA4 regulates the transcription of MMP9 to suppress the invasion and migration of breast cancer cells via HDAC1-mediated p65 deacetylation. Cell Death Dis. 15, 289 (2024).","journal-title":"Cell Death Dis."},{"key":"2764_CR212","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1038\/s41418-018-0268-3","volume":"26","author":"X Ding","year":"2019","unstructured":"Ding, X. et al. Suppression of the SAP18\/HDAC1 complex by targeting TRIM56 and Nanog is essential for oncogenic viral FLICE-inhibitory protein-induced acetylation of p65\/RelA, NF-kappaB activation, and promotion of cell invasion and angiogenesis. Cell Death Differ. 26, 1970\u20131986 (2019).","journal-title":"Cell Death Differ."},{"key":"2764_CR213","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10565-019-09459-7","volume":"35","author":"J Li","year":"2019","unstructured":"Li, J. et al. HDAC2-mediated upregulation of IL-6 triggers the migration of osteosarcoma cells. Cell Biol. Toxicol. 35, 423\u2013433 (2019).","journal-title":"Cell Biol. Toxicol."},{"key":"2764_CR214","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1002\/tox.23825","volume":"38","author":"A Ali","year":"2023","unstructured":"Ali, A. et al. The HDAC2\/YY1\/c-Myc signaling axis regulates lung cancer cell migration and proliferation. Environ. Toxicol. 38, 1989\u20132001 (2023).","journal-title":"Environ. Toxicol."},{"key":"2764_CR215","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1073\/pnas.1218126110","volume":"110","author":"A Nott","year":"2013","unstructured":"Nott, A. et al. S-nitrosylation of HDAC2 regulates the expression of the chromatin-remodeling factor Brm during radial neuron migration. Proc. Natl. Acad. Sci. USA 110, 3113\u20133118 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2764_CR216","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1161\/HYPERTENSIONAHA.113.01843","volume":"63","author":"T Usui","year":"2014","unstructured":"Usui, T., Morita, T., Okada, M. & Yamawaki, H. Histone deacetylase 4 controls neointimal hyperplasia via stimulating proliferation and migration of vascular smooth muscle cells. Hypertension 63, 397\u2013403 (2014).","journal-title":"Hypertension"},{"key":"2764_CR217","doi-asserted-by":"publisher","first-page":"e007572","DOI":"10.1161\/JAHA.117.007572","volume":"7","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. Phosphatidylinositol 3-kinase-DNA methyltransferase 1-miR-1281-histone deacetylase 4 regulatory axis mediates platelet-derived growth factor-induced proliferation and migration of pulmonary artery smooth muscle cells. J. Am. Heart Assoc. 7, e007572 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"2764_CR218","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.canlet.2012.06.017","volume":"325","author":"MY Ahn","year":"2012","unstructured":"Ahn, M. Y. et al. Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing. Cancer Lett. 325, 189\u2013199 (2012).","journal-title":"Cancer Lett."},{"key":"2764_CR219","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/s12276-022-00796-y","volume":"54","author":"SH Jeong","year":"2022","unstructured":"Jeong, S. H. et al. Histone deacetylase 3 promotes alveolar epithelial-mesenchymal transition and fibroblast migration under hypoxic conditions. Exp. Mol. Med. 54, 922\u2013931 (2022).","journal-title":"Exp. Mol. Med"},{"key":"2764_CR220","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1161\/CIRCRESAHA.107.149377","volume":"101","author":"D Mottet","year":"2007","unstructured":"Mottet, D. et al. Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis. Circ. Res. 101, 1237\u20131246 (2007).","journal-title":"Circ. Res."},{"key":"2764_CR221","doi-asserted-by":"publisher","first-page":"7738","DOI":"10.1073\/pnas.0802857105","volume":"105","author":"S Wang","year":"2008","unstructured":"Wang, S. et al. Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7. Proc. Natl. Acad. Sci. USA 105, 7738\u20137743 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2764_CR222","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1093\/nar\/gkaa039","volume":"48","author":"X Tang","year":"2020","unstructured":"Tang, X. et al. HDAC8 cooperates with SMAD3\/4 complex to suppress SIRT7 and promote cell survival and migration. Nucleic Acids Res. 48, 2912\u20132923 (2020).","journal-title":"Nucleic Acids Res."},{"key":"2764_CR223","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jhep.2013.12.004","volume":"60","author":"YW Dong","year":"2014","unstructured":"Dong, Y. W. et al. Sulfatide epigenetically regulates miR-223 and promotes the migration of human hepatocellular carcinoma cells. J. Hepatol. 60, 792\u2013801 (2014).","journal-title":"J. Hepatol."},{"key":"2764_CR224","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41581-022-00601-z","volume":"18","author":"W Huang","year":"2022","unstructured":"Huang, W. et al. Cellular senescence: The good, the bad and the unknown. Nat. Rev. Nephrol. 18, 611\u2013627 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"2764_CR225","doi-asserted-by":"publisher","first-page":"8218","DOI":"10.1093\/nar\/gkae501","volume":"52","author":"E Di Giorgio","year":"2024","unstructured":"Di Giorgio, E. et al. HDAC4 influences the DNA damage response and counteracts senescence by assembling with HDAC1\/HDAC2 to control H2BK120 acetylation and homology-directed repair. Nucleic Acids Res. 52, 8218\u20138240 (2024).","journal-title":"Nucleic Acids Res"},{"key":"2764_CR226","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1681\/ASN.2022050598","volume":"34","author":"PX Medina Rangel","year":"2023","unstructured":"Medina Rangel, P. X. et al. Cell cycle and senescence regulation by podocyte histone deacetylase 1 and 2. J. Am. Soc. Nephrol. 34, 433\u2013450 (2023).","journal-title":"J. Am. Soc. Nephrol."},{"key":"2764_CR227","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.338","volume":"4","author":"Z Lin","year":"2023","unstructured":"Lin, Z. et al. Discovery of deoxyandrographolide and its novel effect on vascular senescence by targeting HDAC1. MedComm (2020) 4, e338 (2023).","journal-title":"MedComm (2020)"},{"key":"2764_CR228","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41413-024-00333-9","volume":"12","author":"B Fu","year":"2024","unstructured":"Fu, B. et al. Matrix stiffening promotes chondrocyte senescence and the osteoarthritis development through downregulating HDAC3. Bone Res. 12, 32 (2024).","journal-title":"Bone Res"},{"key":"2764_CR229","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809854","volume":"11","author":"RL McIntyre","year":"2019","unstructured":"McIntyre, R. L. et al. From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs. EMBO Mol. Med. 11, e9854 (2019).","journal-title":"EMBO Mol. Med"},{"key":"2764_CR230","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"2764_CR231","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.167757","volume":"1871","author":"C Huang","year":"2025","unstructured":"Huang, C. et al. HDCA6 suppresses GATA6 expression to enhance cellular growth and migration in lung squamous cell carcinoma. Biochim Biophys. Acta Mol. Basis Dis. 1871, 167757 (2025).","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"2764_CR232","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/14756366.2020.1839446","volume":"36","author":"S Mehndiratta","year":"2021","unstructured":"Mehndiratta, S. et al. Effect of 3-subsitution of quinolinehydroxamic acids on selectivity of histone deacetylase isoforms. J. Enzym. Inhib. Med Chem. 36, 74\u201384 (2021).","journal-title":"J. Enzym. Inhib. Med Chem."},{"key":"2764_CR233","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jnutbio.2016.12.015","volume":"42","author":"Y Oya","year":"2017","unstructured":"Oya, Y. et al. Down-regulation of histone deacetylase 4, -5 and -6 as a mechanism of synergistic enhancement of apoptosis in human lung cancer cells treated with the combination of a synthetic retinoid, Am80 and green tea catechin. J. Nutr. Biochem 42, 7\u201316 (2017).","journal-title":"J. Nutr. Biochem"},{"key":"2764_CR234","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1158\/1078-0432.CCR-16-2271","volume":"23","author":"A Tanimoto","year":"2017","unstructured":"Tanimoto, A. et al. Histone deacetylase 3 inhibition overcomes BIM deletion polymorphism-mediated osimertinib resistance in EGFR-mutant lung cancer. Clin. Cancer Res. 23, 3139\u20133149 (2017).","journal-title":"Clin. Cancer Res."},{"key":"2764_CR235","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.7150\/ijbs.96509","volume":"21","author":"M Jiang","year":"2025","unstructured":"Jiang, M. et al. DNMT3a promotes LUAD cell proliferation and metastasis by activating the HDAC7 signalling pathway. Int. J. Biol. Sci. 21, 1585\u20131602 (2025).","journal-title":"Int. J. Biol. Sci."},{"key":"2764_CR236","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2015.98","volume":"48","author":"JA Lim","year":"2016","unstructured":"Lim, J. A. & Juhnn, Y. S. Isoproterenol increases histone deacetylase 6 expression and cell migration by inhibiting ERK signaling via PKA and Epac pathways in human lung cancer cells. Exp. Mol. Med. 48, e204 (2016).","journal-title":"Exp. Mol. Med"},{"key":"2764_CR237","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1158\/1078-0432.CCR-14-1150","volume":"21","author":"YC Lin","year":"2015","unstructured":"Lin, Y. C. et al. DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers. Clin. Cancer Res. 21, 428\u2013438 (2015).","journal-title":"Clin. Cancer Res."},{"key":"2764_CR238","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s13402-017-0343-7","volume":"40","author":"S Kaowinn","year":"2017","unstructured":"Kaowinn, S. et al. Increased EGFR expression induced by a novel oncogene, CUG2, confers resistance to doxorubicin through Stat1-HDAC4 signaling. Cell Oncol. (Dordr.) 40, 549\u2013561 (2017).","journal-title":"Cell Oncol. (Dordr.)"},{"key":"2764_CR239","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03973-3","volume":"21","author":"J Cui","year":"2023","unstructured":"Cui, J. et al. HDAC inhibitor ITF2357 reduces resistance of mutant-KRAS non-small cell lung cancer to pemetrexed through a HDAC2\/miR-130a-3p-dependent mechanism. J. Transl. Med. 21, 125 (2023).","journal-title":"J. Transl. Med."},{"key":"2764_CR240","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1158\/0008-5472.CAN-19-3613","volume":"80","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. HDAC10 regulates cancer stem-like cell properties in KRAS-driven lung adenocarcinoma. Cancer Res. 80, 3265\u20133278 (2020).","journal-title":"Cancer Res"},{"key":"2764_CR241","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1007\/s10495-017-1410-2","volume":"22","author":"VR Pidugu","year":"2017","unstructured":"Pidugu, V. R. et al. Novel histone deacetylase 8-selective inhibitor 1,3,4-oxadiazole-alanine hybrid induces apoptosis in breast cancer cells. Apoptosis 22, 1394\u20131403 (2017).","journal-title":"Apoptosis"},{"key":"2764_CR242","doi-asserted-by":"publisher","first-page":"12761","DOI":"10.1074\/jbc.M115.704627","volume":"291","author":"T Dasgupta","year":"2016","unstructured":"Dasgupta, T., Antony, J., Braithwaite, A. W. & Horsfield, J. A. HDAC8 inhibition blocks SMC3 deacetylation and delays cell cycle progression without affecting cohesin-dependent transcription in MCF7 cancer cells. J. Biol. Chem. 291, 12761\u201312770 (2016).","journal-title":"J. Biol. Chem."},{"key":"2764_CR243","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02174-3","volume":"23","author":"S Nimal","year":"2025","unstructured":"Nimal, S. et al. Reversal of epithelial to mesenchymal transition in triple negative breast cancer through epigenetic modulations by dietary flavonoid Galangin and its combination with SAHA. Cell Commun. Signal 23, 163 (2025).","journal-title":"Cell Commun. Signal"},{"key":"2764_CR244","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fphar.2016.00081","volume":"7","author":"JY Lee","year":"2016","unstructured":"Lee, J. Y. et al. Inhibition of HDAC3- and HDAC6-promoted survivin expression plays an important role in SAHA-induced autophagy and viability reduction in breast cancer cells. Front Pharm. 7, 81 (2016).","journal-title":"Front Pharm."},{"key":"2764_CR245","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-018-1046-3","volume":"20","author":"A Sethuraman","year":"2018","unstructured":"Sethuraman, A. et al. BHLHE40 confers a pro-survival and pro-metastatic phenotype to breast cancer cells by modulating HBEGF secretion. Breast Cancer Res. 20, 117 (2018).","journal-title":"Breast Cancer Res"},{"key":"2764_CR246","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41418-024-01271-z","volume":"31","author":"H Chen","year":"2024","unstructured":"Chen, H. et al. Hypoxia-activated XBP1s recruits HDAC2-EZH2 to engage epigenetic suppression of \u0394Np63\u03b1 expression and promote breast cancer metastasis independent of HIF1\u03b1. Cell Death Differ. 31, 447\u2013459 (2024).","journal-title":"Cell Death Differ."},{"key":"2764_CR247","volume":"12","author":"X He","year":"2025","unstructured":"He, X. et al. HDAC2-mediated METTL3 delactylation promotes DNA damage repair and chemotherapy resistance in triple-negative breast cancer. Adv. Sci. (Weinh.) 12, e2413121 (2025).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"2764_CR248","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12929-025-01129-7","volume":"32","author":"Z Gu","year":"2025","unstructured":"Gu, Z. et al. Metformin sensitizes triple-negative breast cancer to histone deacetylase inhibitors by targeting FGFR4. J. Biomed. Sci. 32, 36 (2025).","journal-title":"J. Biomed. Sci."},{"key":"2764_CR249","doi-asserted-by":"publisher","first-page":"107518","DOI":"10.1016\/j.compbiomed.2023.107518","volume":"166","author":"S Khadempar","year":"2023","unstructured":"Khadempar, S. et al. Lansoprazole as a potent HDAC2 inhibitor for treatment of colorectal cancer: An in-silico analysis and experimental validation. Comput Biol. Med. 166, 107518 (2023).","journal-title":"Comput Biol. Med"},{"key":"2764_CR250","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1111\/cas.15571","volume":"113","author":"S Peng","year":"2022","unstructured":"Peng, S. et al. Hsa-microRNA-370-3p targeting Snail and Twist1 suppresses IL-8\/STAT3-driven hepatocellular carcinoma metastasis. Cancer Sci. 113, 4120\u20134134 (2022).","journal-title":"Cancer Sci."},{"key":"2764_CR251","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.7150\/thno.42596","volume":"10","author":"D Li","year":"2020","unstructured":"Li, D. et al. CAMSAP2-mediated noncentrosomal microtubule acetylation drives hepatocellular carcinoma metastasis. Theranostics 10, 3749\u20133766 (2020).","journal-title":"Theranostics"},{"key":"2764_CR252","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/carcin\/bgab039","volume":"42","author":"JF Festa Ortega","year":"2021","unstructured":"Festa Ortega, J. F. et al. Butyrate-containing structured lipids act on HDAC4, HDAC6, DNA damage and telomerase activity during promotion of experimental hepatocarcinogenesis. Carcinogenesis 42, 1026\u20131036 (2021).","journal-title":"Carcinogenesis"},{"key":"2764_CR253","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1158\/2326-6066.CIR-22-0317","volume":"11","author":"L Li","year":"2023","unstructured":"Li, L. et al. HDAC3 inhibition promotes antitumor immunity by enhancing CXCL10-mediated chemotaxis and recruiting of immune cells. Cancer Immunol. Res. 11, 657\u2013673 (2023).","journal-title":"Cancer Immunol. Res"},{"key":"2764_CR254","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05335-1","volume":"13","author":"G Xu","year":"2022","unstructured":"Xu, G. et al. HDAC6-dependent deacetylation of TAK1 enhances sIL-6R release to promote macrophage M2 polarization in colon cancer. Cell Death Dis. 13, 888 (2022).","journal-title":"Cell Death Dis."},{"key":"2764_CR255","doi-asserted-by":"publisher","first-page":"e2102718118","DOI":"10.1073\/pnas.2102718118","volume":"118","author":"S Bugide","year":"2021","unstructured":"Bugide, S., Gupta, R., Green, M. R. & Wajapeyee, N. EZH2 inhibits NK cell-mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner. Proc. Natl. Acad. Sci. USA 118, e2102718118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2764_CR256","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-019-0332-8","volume":"17","author":"M Zhang","year":"2019","unstructured":"Zhang, M. et al. Low levels of pyruvate induced by a positive feedback loop protects cholangiocarcinoma cells from apoptosis. Cell Commun. Signal 17, 23 (2019).","journal-title":"Cell Commun. Signal"},{"key":"2764_CR257","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s00204-018-2229-5","volume":"92","author":"N Kiweler","year":"2018","unstructured":"Kiweler, N. et al. The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells. Arch. Toxicol. 92, 2227\u20132243 (2018).","journal-title":"Arch. Toxicol."},{"key":"2764_CR258","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bcp.2015.11.005","volume":"99","author":"C Seidel","year":"2016","unstructured":"Seidel, C. et al. 4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90alpha chaperone activity against prostate cancer. Biochem Pharm. 99, 31\u201352 (2016).","journal-title":"Biochem Pharm."},{"key":"2764_CR259","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adt3552","volume":"11","author":"H Nam","year":"2025","unstructured":"Nam, H. et al. HDAC7 promotes renal cancer progression by reprogramming branched-chain amino acid metabolism. Sci. Adv. 11, eadt3552 (2025).","journal-title":"Sci. Adv."},{"key":"2764_CR260","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3390\/ijms20051162","volume":"20","author":"FS Hsu","year":"2019","unstructured":"Hsu, F. S. et al. Histone deacetylase inhibitor, trichostatin A, synergistically enhances paclitaxel-induced cytotoxicity in urothelial carcinoma cells by suppressing the ERK pathway. Int J. Mol. Sci. 20, 1162 (2019).","journal-title":"Int J. Mol. Sci."},{"key":"2764_CR261","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1158\/0008-5472.CAN-20-2828","volume":"81","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y. et al. HDAC5 loss impairs RB repression of pro-oncogenic genes and confers CDK4\/6 inhibitor resistance in cancer. Cancer Res. 81, 1486\u20131499 (2021).","journal-title":"Cancer Res."},{"key":"2764_CR262","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.102971","volume":"299","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Acetylation stabilizes the signaling protein WISP2 by preventing its degradation to suppress the progression of acute myeloid leukemia. J. Biol. Chem. 299, 102971 (2023).","journal-title":"J. Biol. Chem."},{"key":"2764_CR263","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40164-023-00383-5","volume":"12","author":"S Gu","year":"2023","unstructured":"Gu, S. et al. Synergistic effect of HDAC inhibitor Chidamide with Cladribine on cell cycle arrest and apoptosis by targeting HDAC2\/c-Myc\/RCC1 axis in acute myeloid leukemia. Exp. Hematol. Oncol. 12, 23 (2023).","journal-title":"Exp. Hematol. Oncol."},{"key":"2764_CR264","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05435-y","volume":"13","author":"M Li","year":"2022","unstructured":"Li, M. et al. HDAC1\/3-dependent moderate liquid-liquid phase separation of YY1 promotes METTL3 expression and AML cell proliferation. Cell Death Dis. 13, 992 (2022).","journal-title":"Cell Death Dis."},{"key":"2764_CR265","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105058","volume":"160","author":"H Losson","year":"2020","unstructured":"Losson, H. et al. The HDAC6 inhibitor 7b induces BCR-ABL ubiquitination and downregulation and synergizes with imatinib to trigger apoptosis in chronic myeloid leukemia. Pharm. Res. 160, 105058 (2020).","journal-title":"Pharm. Res"},{"key":"2764_CR266","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1038\/s41375-025-02612-8","volume":"39","author":"AO Mieland","year":"2025","unstructured":"Mieland, A. O. et al. The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid cells. Leukemia 39, 1756\u20131768 (2025).","journal-title":"Leukemia"},{"key":"2764_CR267","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.154","volume":"10","author":"X Yu","year":"2020","unstructured":"Yu, X. et al. Natural HDAC-1\/8 inhibitor baicalein exerts therapeutic effect in CBF-AML. Clin. Transl. Med 10, e154 (2020).","journal-title":"Clin. Transl. Med"},{"key":"2764_CR268","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02203-8","volume":"24","author":"C Can","year":"2025","unstructured":"Can, C. et al. Exosomal circ_0006896 promotes AML progression via interaction with HDAC1 and restriction of antitumor immunity. Mol. Cancer 24, 4 (2025).","journal-title":"Mol. Cancer"},{"key":"2764_CR269","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.3390\/ijms21165873","volume":"21","author":"Y Sixto-Lopez","year":"2020","unstructured":"Sixto-Lopez, Y. et al. N-(2\u2019-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA) inhibits HDAC1 and increases the translocation of HMGB1 levels in human cervical cancer cells. Int. J. Mol. Sci. 21, 5873 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"2764_CR270","doi-asserted-by":"publisher","first-page":"8645","DOI":"10.3390\/ijms23158645","volume":"23","author":"JY Kim","year":"2022","unstructured":"Kim, J. Y. et al. HDAC8-selective inhibition by PCI-34051 enhances the anticancer effects of ACY-241 in ovarian cancer cells. Int. J. Mol. Sci. 23, 8645 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"2764_CR271","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-018-0231-4","volume":"16","author":"GR Vanaja","year":"2018","unstructured":"Vanaja, G. R., Ramulu, H. G. & Kalle, A. M. Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6. Cell Commun. Signal 16, 20 (2018).","journal-title":"Cell Commun. Signal"},{"key":"2764_CR272","doi-asserted-by":"publisher","first-page":"e1065369","DOI":"10.1080\/2162402X.2015.1065369","volume":"5","author":"JK Peper","year":"2016","unstructured":"Peper, J. K. et al. HLA ligandomics identifies histone deacetylase 1 as target for ovarian cancer immunotherapy. Oncoimmunology 5, e1065369 (2016).","journal-title":"Oncoimmunology"},{"key":"2764_CR273","doi-asserted-by":"publisher","first-page":"e138560","DOI":"10.1172\/JCI138560","volume":"131","author":"AS Truong","year":"2021","unstructured":"Truong, A. S. et al. Entinostat induces antitumor immune responses through immune editing of tumor neoantigens. J. Clin. Invest 131, e138560 (2021).","journal-title":"J. Clin. Invest"},{"key":"2764_CR274","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1158\/1078-0432.CCR-21-2857","volume":"28","author":"TTT Nguyen","year":"2022","unstructured":"Nguyen, T. T. T. et al. Induction of synthetic lethality by activation of mitochondrial ClpP and inhibition of HDAC1\/2 in glioblastoma. Clin. Cancer Res. 28, 1881\u20131895 (2022).","journal-title":"Clin. Cancer Res"},{"key":"2764_CR275","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-015-0201-7","volume":"3","author":"J Ecker","year":"2015","unstructured":"Ecker, J. et al. Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma. Acta Neuropathol. Commun. 3, 22 (2015).","journal-title":"Acta Neuropathol. Commun."},{"key":"2764_CR276","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13046-022-02257-w","volume":"41","author":"AC Wu","year":"2022","unstructured":"Wu, A. C. et al. HDAC6 involves in regulating the lncRNA-microRNA-mRNA network to promote the proliferation of glioblastoma cells. J. Exp. Clin. Cancer Res. 41, 47 (2022).","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"2764_CR277","volume":"12","author":"GW Kim","year":"2025","unstructured":"Kim, G. W. et al. HDAC6 and USP9X control glutamine metabolism by stabilizing GS to promote glioblastoma tumorigenesis. Adv. Sci. (Weinh.) 12, e2501553 (2025).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"2764_CR278","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s13046-021-02135-x","volume":"40","author":"R Vengoji","year":"2021","unstructured":"Vengoji, R. et al. Differential gene expression-based connectivity mapping identified novel drug candidate and improved Temozolomide efficacy for Glioblastoma. J. Exp. Clin. Cancer Res. 40, 335 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2764_CR279","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03417-0","volume":"12","author":"C Cheng","year":"2021","unstructured":"Cheng, C. et al. HDAC4 promotes nasopharyngeal carcinoma progression and serves as a therapeutic target. Cell Death Dis. 12, 137 (2021).","journal-title":"Cell Death Dis."},{"key":"2764_CR280","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1182\/bloodadvances.2022007155","volume":"7","author":"T Harada","year":"2023","unstructured":"Harada, T. et al. Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase. Blood Adv. 7, 1019\u20131032 (2023).","journal-title":"Blood Adv."},{"key":"2764_CR281","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1038\/leu.2017.144","volume":"31","author":"T Harada","year":"2017","unstructured":"Harada, T. et al. HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications. Leukemia 31, 2670\u20132677 (2017).","journal-title":"Leukemia"},{"key":"2764_CR282","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1158\/0008-5472.CAN-15-2680","volume":"76","author":"A Krumm","year":"2016","unstructured":"Krumm, A. et al. Enhanced histone deacetylase activity in malignant melanoma provokes RAD51 and FANCD2-triggered drug resistance. Cancer Res. 76, 3067\u20133077 (2016).","journal-title":"Cancer Res"},{"key":"2764_CR283","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.molonc.2015.04.002","volume":"9","author":"KV Woan","year":"2015","unstructured":"Woan, K. V. et al. Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation. Mol. Oncol. 9, 1447\u20131457 (2015).","journal-title":"Mol. Oncol."},{"key":"2764_CR284","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa2206916","volume":"389","author":"Global Cardiovascular Risk, C.","year":"2023","unstructured":"Global Cardiovascular Risk, C. et al. Global effect of modifiable risk factors on cardiovascular disease and mortality. N. Engl. J. Med. 389, 1273\u20131285 (2023).","journal-title":"N. Engl. J. Med."},{"key":"2764_CR285","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12931-021-01832-7","volume":"22","author":"F Li","year":"2021","unstructured":"Li, F. et al. Inhibition of HDAC1 alleviates monocrotaline-induced pulmonary arterial remodeling through up-regulation of miR-34a. Respir. Res. 22, 239 (2021).","journal-title":"Respir. Res"},{"key":"2764_CR286","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.vph.2015.04.005","volume":"73","author":"Q Yang","year":"2015","unstructured":"Yang, Q., Sun, M., Ramchandran, R. & Raj, J. U. IGF-1 signaling in neonatal hypoxia-induced pulmonary hypertension: Role of epigenetic regulation. Vasc. Pharm. 73, 20\u201331 (2015).","journal-title":"Vasc. Pharm."},{"key":"2764_CR287","doi-asserted-by":"crossref","unstructured":"Gallardo-Vara, E. et al. Vascular pathobiology of pulmonary hypertension. J Heart Lung Transplant. 42, 544\u2013552 (2023).","DOI":"10.1016\/j.healun.2022.12.012"},{"key":"2764_CR288","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bcp.2014.07.011","volume":"91","author":"M Galletti","year":"2014","unstructured":"Galletti, M. et al. Dissecting histone deacetylase role in pulmonary arterial smooth muscle cell proliferation and migration. Biochem Pharm. 91, 181\u2013190 (2014).","journal-title":"Biochem Pharm."},{"key":"2764_CR289","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/cpr.12076","volume":"46","author":"Q Yang","year":"2013","unstructured":"Yang, Q. et al. Role of histone deacetylases in regulation of phenotype of ovine newborn pulmonary arterial smooth muscle cells. Cell Prolif. 46, 654\u2013664 (2013).","journal-title":"Cell Prolif."},{"key":"2764_CR290","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1161\/CIRCULATIONAHA.114.013339","volume":"131","author":"J Kim","year":"2015","unstructured":"Kim, J. et al. Restoration of impaired endothelial myocyte enhancer factor 2 function rescues pulmonary arterial hypertension. Circulation 131, 190\u2013199 (2015).","journal-title":"Circulation"},{"key":"2764_CR291","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1164\/rccm.202301-0181OC","volume":"208","author":"CN Chen","year":"2023","unstructured":"Chen, C. N. et al. Restoration of Foxp3(+) regulatory T cells by HDAC-dependent epigenetic modulation plays a pivotal role in resolving pulmonary arterial hypertension pathology. Am. J. Respir. Crit. Care Med 208, 879\u2013895 (2023).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"2764_CR292","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","volume":"185","author":"JLM Bj\u00f6rkegren","year":"2022","unstructured":"Bj\u00f6rkegren, J. L. M. & Lusis, A. J. Atherosclerosis: Recent developments. Cell 185, 1630\u20131645 (2022).","journal-title":"Cell"},{"key":"2764_CR293","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1161\/ATVBAHA.114.303685","volume":"34","author":"D Pandey","year":"2014","unstructured":"Pandey, D. et al. Transcriptional regulation of endothelial arginase 2 by histone deacetylase 2. Arterioscler Thromb. Vasc. Biol. 34, 1556\u20131566 (2014).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"2764_CR294","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1161\/CIRCRESAHA.120.316743","volume":"127","author":"Y Asare","year":"2020","unstructured":"Asare, Y. et al. Histone deacetylase 9 activates IKK to regulate atherosclerotic plaque vulnerability. Circ. Res. 127, 811\u2013823 (2020).","journal-title":"Circ. Res."},{"key":"2764_CR295","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.673366","volume":"12","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Traditional Chinese medication tongxinluo attenuates lipidosis in Ox-LDL-stimulated macrophages by enhancing beclin-1-induced autophagy. Front Pharm. 12, 673366 (2021).","journal-title":"Front Pharm."},{"key":"2764_CR296","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41420-022-00906-9","volume":"8","author":"F Yao","year":"2022","unstructured":"Yao, F. et al. HDAC11 promotes both NLRP3\/caspase-1\/GSDMD and caspase-3\/GSDME pathways causing pyroptosis via ERG in vascular endothelial cells. Cell Death Discov. 8, 112 (2022).","journal-title":"Cell Death Discov."},{"key":"2764_CR297","doi-asserted-by":"publisher","first-page":"e131178","DOI":"10.1172\/JCI131178","volume":"131","author":"L Lecce","year":"2021","unstructured":"Lecce, L. et al. Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotype. J. Clin. Invest 131, e131178 (2021).","journal-title":"J. Clin. Invest"},{"key":"2764_CR298","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1161\/CIRCULATIONAHA.109.890491","volume":"121","author":"A Zampetaki","year":"2010","unstructured":"Zampetaki, A. et al. Histone deacetylase 3 is critical in endothelial survival and atherosclerosis development in response to disturbed flow. Circulation 121, 132\u2013142 (2010).","journal-title":"Circulation"},{"key":"2764_CR299","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura, M. & Sadoshima, J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat. Rev. Cardiol. 15, 387\u2013407 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"2764_CR300","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/cvr\/cvaf008","volume":"121","author":"W Liu","year":"2025","unstructured":"Liu, W. et al. Down-regulation of histone deacetylase 2 attenuates ventricular arrhythmias in a mouse model of cardiac hypertrophy through up-regulation of Kv channel-interacting protein 2 expression. Cardiovasc Res. 121, 424\u2013439 (2025).","journal-title":"Cardiovasc Res"},{"key":"2764_CR301","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/cvr\/cvu254","volume":"105","author":"M Yan","year":"2015","unstructured":"Yan, M. et al. miR-21-3p regulates cardiac hypertrophic response by targeting histone deacetylase-8. Cardiovasc Res. 105, 340\u2013352 (2015).","journal-title":"Cardiovasc Res."},{"key":"2764_CR302","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1172\/JCI61084","volume":"123","author":"M Hohl","year":"2013","unstructured":"Hohl, M. et al. HDAC4 controls histone methylation in response to elevated cardiac load. J. Clin. Invest 123, 1359\u20131370 (2013).","journal-title":"J. Clin. Invest"},{"key":"2764_CR303","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.yjmcc.2020.05.018","volume":"145","author":"T He","year":"2020","unstructured":"He, T. et al. Cyclic AMP represses pathological MEF2 activation by myocyte-specific hypo-phosphorylation of HDAC5. J. Mol. Cell Cardiol. 145, 88\u201398 (2020).","journal-title":"J. Mol. Cell Cardiol."},{"key":"2764_CR304","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nm.4452","volume":"24","author":"LH Lehmann","year":"2018","unstructured":"Lehmann, L. H. et al. A proteolytic fragment of histone deacetylase 4 protects the heart from failure by regulating the hexosamine biosynthetic pathway. Nat. Med 24, 62\u201372 (2018).","journal-title":"Nat. Med"},{"key":"2764_CR305","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nm1552","volume":"13","author":"CM Trivedi","year":"2007","unstructured":"Trivedi, C. M. et al. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat. Med. 13, 324\u2013331 (2007).","journal-title":"Nat. Med."},{"key":"2764_CR306","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/HYPERTENSIONAHA.110.154567","volume":"56","author":"JP Cardinale","year":"2010","unstructured":"Cardinale, J. P. et al. HDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats. Hypertension 56, 437\u2013444 (2010).","journal-title":"Hypertension"},{"key":"2764_CR307","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104281","volume":"146","author":"Z Chi","year":"2019","unstructured":"Chi, Z. et al. Histone deacetylase 6 inhibitor tubastatin A attenuates angiotensin II-induced hypertension by preventing cystathionine gamma-lyase protein degradation. Pharm. Res. 146, 104281 (2019).","journal-title":"Pharm. Res"},{"key":"2764_CR308","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.113.301071","volume":"112","author":"HA Lee","year":"2013","unstructured":"Lee, H. A. et al. Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension. Circ. Res. 112, 1004\u20131012 (2013).","journal-title":"Circ. Res"},{"key":"2764_CR309","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.yjmcc.2018.04.011","volume":"119","author":"D Kimbrough","year":"2018","unstructured":"Kimbrough, D. et al. HDAC inhibition helps post-MI healing by modulating macrophage polarization. J. Mol. Cell Cardiol. 119, 51\u201363 (2018).","journal-title":"J. Mol. Cell Cardiol."},{"key":"2764_CR310","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1096\/fj.08-108548","volume":"22","author":"A Granger","year":"2008","unstructured":"Granger, A. et al. Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J. 22, 3549\u20133560 (2008).","journal-title":"FASEB J."},{"key":"2764_CR311","doi-asserted-by":"publisher","first-page":"e95824","DOI":"10.1172\/jci.insight.95824","volume":"3","author":"LH Wright","year":"2018","unstructured":"Wright, L. H. et al. Angiokine Wisp-1 is increased in myocardial infarction and regulates cardiac endothelial signaling. JCI Insight 3, e95824 (2018).","journal-title":"JCI Insight"},{"key":"2764_CR312","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.yjmcc.2017.12.004","volume":"114","author":"DJ Herr","year":"2018","unstructured":"Herr, D. J. et al. HDAC1 localizes to the mitochondria of cardiac myocytes and contributes to early cardiac reperfusion injury. J. Mol. Cell Cardiol. 114, 309\u2013319 (2018).","journal-title":"J. Mol. Cell Cardiol."},{"key":"2764_CR313","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s10020-018-0037-2","volume":"24","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. Myocyte-specific overexpressing HDAC4 promotes myocardial ischemia\/reperfusion injury. Mol. Med. 24, 37 (2018).","journal-title":"Mol. Med."},{"key":"2764_CR314","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.yjmcc.2013.12.013","volume":"67","author":"SM Williams","year":"2014","unstructured":"Williams, S. M. et al. Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes. J. Mol. Cell Cardiol. 67, 112\u2013125 (2014).","journal-title":"J. Mol. Cell Cardiol."},{"key":"2764_CR315","doi-asserted-by":"crossref","unstructured":"Moore IV, J. B. et al. Epigenetically modified cardiac mesenchymal stromal cells limit myocardial fibrosis and promote functional recovery in a model of chronic ischemic cardiomyopathy. Basic Res. Cardiol. 114, 3 (2018).","DOI":"10.1007\/s00395-018-0710-1"},{"key":"2764_CR316","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jare.2025.05.035","volume":"80","author":"X Weng","year":"2025","unstructured":"Weng, X. et al. Ketogenic diet and beta-hydroxybutyrate inhibit HDAC1 to preserve vascular smooth muscle cell function in thoracic aortic aneurysm. J. Adv. Res. 80, 475\u2013486 (2025).","journal-title":"J. Adv. Res"},{"key":"2764_CR317","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1042\/CS20170064","volume":"131","author":"Z Xu","year":"2017","unstructured":"Xu, Z. et al. Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1\/2 pathway. Clin. Sci. (Lond.) 131, 1841\u20131857 (2017).","journal-title":"Clin. Sci. (Lond.)"},{"key":"2764_CR318","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1136\/thoraxjnl-2014-206411","volume":"70","author":"M Korfei","year":"2015","unstructured":"Korfei, M. et al. Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis. Thorax 70, 1022\u20131032 (2015).","journal-title":"Thorax"},{"key":"2764_CR319","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12929-023-00931-5","volume":"30","author":"HS Hua","year":"2023","unstructured":"Hua, H. S. et al. Endothelin-1 induces connective tissue growth factor expression in human lung fibroblasts by disrupting HDAC2\/Sin3A\/MeCP2 corepressor complex. J. Biomed. Sci. 30, 40 (2023).","journal-title":"J. Biomed. Sci."},{"key":"2764_CR320","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nchembio.275","volume":"6","author":"DM Hutt","year":"2010","unstructured":"Hutt, D. M. et al. Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. Nat. Chem. Biol. 6, 25\u201333 (2010).","journal-title":"Nat. Chem. Biol."},{"key":"2764_CR321","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1165\/rcmb.2007-0464OC","volume":"40","author":"TR Bartling","year":"2009","unstructured":"Bartling, T. R. & Drumm, M. L. Oxidative stress causes IL8 promoter hyperacetylation in cystic fibrosis airway cell models. Am. J. Respir. Cell Mol. Biol. 40, 58\u201365 (2009).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2764_CR322","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1183\/09031936.00095113","volume":"43","author":"YY Sanders","year":"2014","unstructured":"Sanders, Y. Y. et al. Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice. Eur. Respir. J. 43, 1448\u20131458 (2014).","journal-title":"Eur. Respir. J."},{"key":"2764_CR323","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1056\/NEJMoa041892","volume":"352","author":"K Ito","year":"2005","unstructured":"Ito, K. et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N. Engl. J. Med. 352, 1967\u20131976 (2005).","journal-title":"N. Engl. J. Med."},{"key":"2764_CR324","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1378\/chest.11-1536","volume":"141","author":"M To","year":"2012","unstructured":"To, M. et al. Defect of adaptation to hypoxia in patients with COPD due to reduction of histone deacetylase 7. Chest 141, 1233\u20131242 (2012).","journal-title":"Chest"},{"key":"2764_CR325","doi-asserted-by":"publisher","first-page":"L402","DOI":"10.1152\/ajplung.00207.2010","volume":"300","author":"S Mizuno","year":"2011","unstructured":"Mizuno, S. et al. Inhibition of histone deacetylase causes emphysema. Am. J. Physiol. Lung Cell Mol. Physiol. 300, L402\u2013L413 (2011).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"2764_CR326","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1164\/rccm.200305-659OC","volume":"170","author":"BG Cosio","year":"2004","unstructured":"Cosio, B. G. et al. Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. Am. J. Respir. Crit. Care Med 170, 141\u2013147 (2004).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"2764_CR327","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jaci.2016.03.050","volume":"139","author":"P Wawrzyniak","year":"2017","unstructured":"Wawrzyniak, P. et al. Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients. J. Allergy Clin. Immunol. 139, 93\u2013103 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2764_CR328","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12931-020-1322-5","volume":"21","author":"ML Li","year":"2020","unstructured":"Li, M. L. et al. HDAC8 inhibitor attenuates airway responses to antigen stimulus through synchronously suppressing galectin-3 expression and reducing macrophage-2 polarization. Respir. Res. 21, 62 (2020).","journal-title":"Respir. Res"},{"key":"2764_CR329","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12931-024-02891-2","volume":"25","author":"Y Xiang","year":"2024","unstructured":"Xiang, Y. et al. Myeloid-specific Hdac10 deletion protects against LPS-induced acute lung injury via P62 acetylation at lysine 165. Respir. Res. 25, 263 (2024).","journal-title":"Respir. Res"},{"key":"2764_CR330","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1165\/rcmb.2015-0149OC","volume":"54","author":"D Borgas","year":"2016","unstructured":"Borgas, D. et al. Cigarette smoke disrupted lung endothelial barrier integrity and increased susceptibility to acute lung injury via histone deacetylase 6. Am. J. Respir. Cell Mol. Biol. 54, 683\u2013696 (2016).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2764_CR331","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.cgh.2021.06.047","volume":"20","author":"SC Mathews","year":"2022","unstructured":"Mathews, S. C. et al. Prevalence and financial burden of digestive diseases in a commercially insured population. Clin. Gastroenterol. Hepatol. 20, 1480\u20131487.e1487 (2022).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2764_CR332","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1001\/jama.2024.0948","volume":"331","author":"L Spacek","year":"2024","unstructured":"Spacek, L. Clinical guidelines on nonalcoholic fatty liver disease. Jama 331, 1062\u20131063 (2024).","journal-title":"Jama"},{"key":"2764_CR333","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1126\/science.1198125","volume":"331","author":"D Feng","year":"2011","unstructured":"Feng, D. et al. A circa dian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science 331, 1315\u20131319 (2011).","journal-title":"Science"},{"key":"2764_CR334","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00215-1","volume":"8","author":"K Kim","year":"2017","unstructured":"Kim, K. et al. RORalpha controls hepatic lipid homeostasis via negative regulation of PPARgamma transcriptional network. Nat. Commun. 8, 162 (2017).","journal-title":"Nat. Commun."},{"key":"2764_CR335","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1194\/jlr.M080382","volume":"59","author":"X Qiu","year":"2018","unstructured":"Qiu, X. et al. HDAC5 integrates ER stress and fasting signals to regulate hepatic fatty acid oxidation. J. Lipid Res. 59, 330\u2013338 (2018).","journal-title":"J. Lipid Res"},{"key":"2764_CR336","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/path.5758","volume":"255","author":"H Kang","year":"2021","unstructured":"Kang, H. et al. The loss of histone deacetylase 4 in macrophages exacerbates hepatic and adipose tissue inflammation in male but not in female mice with diet-induced non-alcoholic steatohepatitis. J. Pathol. 255, 319\u2013329 (2021).","journal-title":"J. Pathol."},{"key":"2764_CR337","doi-asserted-by":"publisher","first-page":"7633","DOI":"10.1021\/acs.jafc.8b01189","volume":"66","author":"B Sun","year":"2018","unstructured":"Sun, B. et al. Sodium butyrate ameliorates high-fat-diet-induced non-alcoholic fatty liver disease through peroxisome proliferator-activated receptor alpha-mediated activation of beta oxidation and suppression of inflammation. J. Agric Food Chem. 66, 7633\u20137642 (2018).","journal-title":"J. Agric Food Chem."},{"key":"2764_CR338","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd1206","volume":"13","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Targeting epigenetically maladapted vascular niche alleviates liver fibrosis in nonalcoholic steatohepatitis. Sci. Transl. Med 13, eabd1206 (2021).","journal-title":"Sci. Transl. Med"},{"key":"2764_CR339","volume":"11","author":"Y Qin","year":"2024","unstructured":"Qin, Y. et al. HOXA-AS2 epigenetically inhibits HBV transcription by recruiting the MTA1-HDAC1\/2 deacetylase complex to cccDNA minichromosome. Adv. Sci. (Weinh.) 11, e2306810 (2024).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"2764_CR340","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104619","volume":"172","author":"Y Yuan","year":"2019","unstructured":"Yuan, Y. et al. HDAC11 restricts HBV replication through epigenetic repression of cccDNA transcription. Antivir. Res. 172, 104619 (2019).","journal-title":"Antivir. Res"},{"key":"2764_CR341","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41401-021-00765-7","volume":"43","author":"LN Zhao","year":"2022","unstructured":"Zhao, L. N. et al. IFN-alpha inhibits HBV transcription and replication by promoting HDAC3-mediated de-2-hydroxyisobutyrylation of histone H4K8 on HBV cccDNA minichromosome in liver. Acta Pharm. Sin. 43, 1484\u20131494 (2022).","journal-title":"Acta Pharm. Sin."},{"key":"2764_CR342","doi-asserted-by":"publisher","first-page":"e1008802","DOI":"10.1371\/journal.ppat.1008802","volume":"16","author":"TY Taha","year":"2020","unstructured":"Taha, T. Y. et al. Modulation of hepatitis B virus pregenomic RNA stability and splicing by histone deacetylase 5 enhances viral biosynthesis. PLoS Pathog. 16, e1008802 (2020).","journal-title":"PLoS Pathog."},{"key":"2764_CR343","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s12250-018-0057-7","volume":"33","author":"Y Zhou","year":"2018","unstructured":"Zhou, Y. et al. Histone Deacetylase 3 Inhibitor Suppresses Hepatitis C Virus Replication by Regulating Apo-A1 and LEAP-1 Expression. Virol. Sin. 33, 418\u2013428 (2018).","journal-title":"Virol. Sin."},{"key":"2764_CR344","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/hep.22486","volume":"48","author":"K Miura","year":"2008","unstructured":"Miura, K. et al. Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology 48, 1420\u20131429 (2008).","journal-title":"Hepatology"},{"key":"2764_CR345","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1038\/onc.2015.428","volume":"35","author":"D Nie","year":"2016","unstructured":"Nie, D. et al. Hepatitis C virus core protein interacts with Snail and histone deacetylases to promote the metastasis of hepatocellular carcinoma. Oncogene 35, 3626\u20133635 (2016).","journal-title":"Oncogene"},{"key":"2764_CR346","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.cgh.2022.06.030","volume":"21","author":"MJ Buie","year":"2023","unstructured":"Buie, M. J. et al. Global hospitalization trends for Crohn\u2019s disease and ulcerative colitis in the 21st century: A systematic review with temporal analyses. Clin. Gastroenterol. Hepatol. 21, 2211\u20132221 (2023).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2764_CR347","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1093\/ibd\/izz317","volume":"26","author":"JW Lee","year":"2020","unstructured":"Lee, J. W. et al. Novel histone deacetylase 6 inhibitor CKD-506 inhibits NF-kappab signaling in intestinal epithelial cells and macrophages and ameliorates acute and chronic murine colitis. Inflamm. Bowel Dis. 26, 852\u2013862 (2020).","journal-title":"Inflamm. Bowel Dis."},{"key":"2764_CR348","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1053\/j.gastro.2009.10.037","volume":"138","author":"EF de Zoeten","year":"2010","unstructured":"de Zoeten, E. F. et al. Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice. Gastroenterology 138, 583\u2013594 (2010).","journal-title":"Gastroenterology"},{"key":"2764_CR349","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2127444","volume":"14","author":"M Chervy","year":"2022","unstructured":"Chervy, M. et al. Epigenetic master regulators HDAC1 and HDAC5 control pathobiont Enterobacteria colonization in ileal mucosa of Crohn\u2019s disease patients. Gut Microbes 14, 2127444 (2022).","journal-title":"Gut Microbes"},{"key":"2764_CR350","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/ecco-jcc\/jjad209","volume":"18","author":"A Lewis","year":"2024","unstructured":"Lewis, A. et al. Epigenetic and metabolic reprogramming of fibroblasts in Crohn\u2019s disease strictures reveals histone deacetylases as therapeutic targets. J. Crohns Colitis 18, 895\u2013907 (2024).","journal-title":"J. Crohns Colitis"},{"key":"2764_CR351","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature12687","volume":"504","author":"T Alenghat","year":"2013","unstructured":"Alenghat, T. et al. Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis. Nature 504, 153\u2013157 (2013).","journal-title":"Nature"},{"key":"2764_CR352","doi-asserted-by":"publisher","first-page":"e162190","DOI":"10.1172\/JCI162190","volume":"133","author":"EM Eshleman","year":"2023","unstructured":"Eshleman, E. M. et al. Intestinal epithelial HDAC3 and MHC class II coordinate microbiota-specific immunity. J. Clin. Invest 133, e162190 (2023).","journal-title":"J. Clin. Invest"},{"key":"2764_CR353","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41575-018-0087-5","volume":"16","author":"MS Petrov","year":"2019","unstructured":"Petrov, M. S. & Yadav, D. Global epidemiology and holistic prevention of pancreatitis. Nat. Rev. Gastroenterol. Hepatol. 16, 175\u2013184 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2764_CR354","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03296-x","volume":"12","author":"X Deng","year":"2021","unstructured":"Deng, X., He, Y., Miao, X. & Yu, B. ATF4-mediated histone deacetylase HDAC1 promotes the progression of acute pancreatitis. Cell Death Dis. 12, 5 (2021).","journal-title":"Cell Death Dis."},{"key":"2764_CR355","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12033-023-00718-x","volume":"66","author":"J Yang","year":"2024","unstructured":"Yang, J. & Li, R. Single-cell sequencing data analysis unveiled HDAC1 as the therapeutic target for chronic pancreatitis. Mol. Biotechnol. 66, 68\u201378 (2024).","journal-title":"Mol. Biotechnol."},{"key":"2764_CR356","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1124\/mol.117.110924","volume":"94","author":"M Bombardo","year":"2018","unstructured":"Bombardo, M. et al. Inhibition of class I histone deacetylases abrogates tumor growth factor beta expression and development of fibrosis during chronic pancreatitis. Mol. Pharm. 94, 793\u2013801 (2018).","journal-title":"Mol. Pharm."},{"key":"2764_CR357","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1016\/j.ajpath.2015.08.006","volume":"185","author":"JF Eisses","year":"2015","unstructured":"Eisses, J. F. et al. Valproic acid limits pancreatic recovery after pancreatitis by inhibiting histone deacetylases and preventing acinar redifferentiation programs. Am. J. Pathol. 185, 3304\u20133315 (2015).","journal-title":"Am. J. Pathol."},{"key":"2764_CR358","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301445RR","volume":"38","author":"J Pan","year":"2024","unstructured":"Pan, J. et al. Histone deacetylase 6 deficiency protects the liver against ischemia\/reperfusion injury by activating PI3K\/AKT\/mTOR signaling. FASEB J. 38, e23477 (2024).","journal-title":"FASEB J."},{"key":"2764_CR359","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1097\/TP.0000000000005042","volume":"108","author":"SJ Concors","year":"2024","unstructured":"Concors, S. J. et al. Differential effects of HDAC6 inhibition versus knockout during hepatic ischemia-reperfusion injury highlight importance of HDAC6 C-terminal zinc-finger ubiquitin-binding domain. Transplantation 108, 2084\u20132092 (2024).","journal-title":"Transplantation"},{"key":"2764_CR360","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03317-9","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Histone deacetylase 2 regulates ULK1 mediated pyroptosis during acute liver failure by the K68 acetylation site. Cell Death Dis. 12, 55 (2021).","journal-title":"Cell Death Dis."},{"key":"2764_CR361","first-page":"1173","volume":"34","author":"Y Liu","year":"2019","unstructured":"Liu, Y. et al. HDAC2 inhibitor CAY10683 reduces intestinal epithelial cell apoptosis by inhibiting mitochondrial apoptosis pathway in acute liver failure. Histol. Histopathol. 34, 1173\u20131184 (2019).","journal-title":"Histol. Histopathol."},{"key":"2764_CR362","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114312","volume":"183","author":"CH Lee","year":"2021","unstructured":"Lee, C. H. et al. Histone deacetylase 8 inhibition alleviates cholestatic liver injury and fibrosis. Biochem Pharm. 183, 114312 (2021).","journal-title":"Biochem Pharm."},{"key":"2764_CR363","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/hep.27959","volume":"62","author":"L Barbier-Torres","year":"2015","unstructured":"Barbier-Torres, L. et al. Histone deacetylase 4 promotes cholestatic liver injury in the absence of prohibitin-1. Hepatology 62, 1237\u20131248 (2015).","journal-title":"Hepatology"},{"key":"2764_CR364","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111861","volume":"131","author":"GD Zhang","year":"2024","unstructured":"Zhang, G. D. et al. A novel HDAC6 inhibitor attenuate APAP-induced liver injury by regulating MDH1-mediated oxidative stress. Int Immunopharmacol. 131, 111861 (2024).","journal-title":"Int Immunopharmacol."},{"key":"2764_CR365","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106882","volume":"26","author":"T Guo","year":"2023","unstructured":"Guo, T. et al. Elevated expression of histone deacetylase HDAC8 suppresses arginine-proline metabolism in necrotizing enterocolitis. iScience 26, 106882 (2023).","journal-title":"iScience"},{"key":"2764_CR366","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1111\/all.15069","volume":"77","author":"MTA Kleuskens","year":"2022","unstructured":"Kleuskens, M. T. A. et al. Butyrate and propionate restore interleukin 13-compromised esophageal epithelial barrier function. Allergy 77, 1510\u20131521 (2022).","journal-title":"Allergy"},{"key":"2764_CR367","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/genes14020347","volume":"14","author":"DA Santana","year":"2023","unstructured":"Santana, D. A., Smith, M. A. C. & Chen, E. S. Histone modifications in Alzheimer\u2019s disease. Genes (Basel) 14, 347 (2023).","journal-title":"Genes (Basel)"},{"key":"2764_CR368","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/1570159X19666210609160017","volume":"20","author":"V Kumar","year":"2022","unstructured":"Kumar, V., Kundu, S., Singh, A. & Singh, S. Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective. Curr. Neuropharmacol. 20, 158\u2013178 (2022).","journal-title":"Curr. Neuropharmacol."},{"key":"2764_CR369","doi-asserted-by":"publisher","first-page":"6565","DOI":"10.1039\/D0FO00161A","volume":"11","author":"S Wu","year":"2020","unstructured":"Wu, S. et al. Up-regulation of neprilysin mediates the protection of fructo-oligosaccharides against Alzheimer\u2019s disease. Food Funct. 11, 6565\u20136572 (2020).","journal-title":"Food Funct."},{"key":"2764_CR370","volume":"11","author":"P Mondal","year":"2024","unstructured":"Mondal, P. et al. Structure-based discovery of A small molecule inhibitor of histone deacetylase 6 (HDAC6) that significantly reduces Alzheimer\u2019s disease neuropathology. Adv. Sci. (Weinh.) 11, e2304545 (2024).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"2764_CR371","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/acel.12642","volume":"16","author":"X Zhu","year":"2017","unstructured":"Zhu, X. et al. HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer\u2019s disease. Aging Cell 16, 1073\u20131082 (2017).","journal-title":"Aging Cell"},{"key":"2764_CR372","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/alzrt259","volume":"6","author":"C Cook","year":"2014","unstructured":"Cook, C. et al. Acetylation: A new key to unlock tau\u2019s role in neurodegeneration. Alzheimers Res. Ther. 6, 29 (2014).","journal-title":"Alzheimers Res. Ther."},{"key":"2764_CR373","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113821","volume":"225","author":"XX Wang","year":"2021","unstructured":"Wang, X. X. et al. Synthesis and biological evaluation of selective histone deacetylase 6 inhibitors as multifunctional agents against Alzheimer\u2019s disease. Eur. J. Med. Chem. 225, 113821 (2021).","journal-title":"Eur. J. Med. Chem."},{"key":"2764_CR374","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-025-00796-2","volume":"20","author":"J Ye","year":"2025","unstructured":"Ye, J. et al. Upregulated astrocyte HDAC7 induces Alzheimer-like tau pathologies via deacetylating transcription factor-EB and inhibiting lysosome biogenesis. Mol. Neurodegener. 20, 5 (2025).","journal-title":"Mol. Neurodegener."},{"key":"2764_CR375","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.celrep.2017.07.044","volume":"20","author":"H Yamakawa","year":"2017","unstructured":"Yamakawa, H. et al. The transcription factor Sp3 cooperates with HDAC2 to regulate synaptic function and plasticity in neurons. Cell Rep. 20, 1319\u20131334 (2017).","journal-title":"Cell Rep."},{"key":"2764_CR376","doi-asserted-by":"publisher","first-page":"7538","DOI":"10.1523\/JNEUROSCI.0260-15.2015","volume":"35","author":"A Sen","year":"2015","unstructured":"Sen, A., Nelson, T. J. & Alkon, D. L. ApoE4 and abeta oligomers reduce BDNF expression via HDAC nuclear translocation. J. Neurosci. 35, 7538\u20137551 (2015).","journal-title":"J. Neurosci."},{"key":"2764_CR377","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nn.3618","volume":"17","author":"B Bie","year":"2014","unstructured":"Bie, B. et al. Epigenetic suppression of neuroligin 1 underlies amyloid-induced memory deficiency. Nat. Neurosci. 17, 223\u2013231 (2014).","journal-title":"Nat. Neurosci."},{"key":"2764_CR378","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1007\/s12035-017-0490-x","volume":"55","author":"P Singh","year":"2018","unstructured":"Singh, P. & Thakur, M. K. Histone deacetylase 2 inhibition attenuates downregulation of hippocampal plasticity gene expression during aging. Mol. Neurobiol. 55, 2432\u20132442 (2018).","journal-title":"Mol. Neurobiol."},{"key":"2764_CR379","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/nan.12518","volume":"45","author":"L Mahady","year":"2019","unstructured":"Mahady, L. et al. HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer\u2019s disease. Neuropathol. Appl Neurobiol. 45, 380\u2013397 (2019).","journal-title":"Neuropathol. Appl Neurobiol."},{"key":"2764_CR380","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30653-5","volume":"13","author":"TA Pascoal","year":"2022","unstructured":"Pascoal, T. A. et al. [(11)C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer\u2019s disease. Nat. Commun. 13, 4171 (2022).","journal-title":"Nat. Commun."},{"key":"2764_CR381","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912 (2015).","journal-title":"Lancet"},{"key":"2764_CR382","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1523\/JNEUROSCI.1419-21.2022","volume":"42","author":"X Xu","year":"2022","unstructured":"Xu, X. et al. CREB Inactivation by HDAC1\/PP1gamma contributes to dopaminergic neurodegeneration in Parkinson\u2019s disease. J. Neurosci. 42, 4594\u20134604 (2022).","journal-title":"J. Neurosci."},{"key":"2764_CR383","doi-asserted-by":"publisher","first-page":"6970","DOI":"10.1007\/s12035-016-0199-2","volume":"54","author":"Q Wu","year":"2017","unstructured":"Wu, Q. et al. Nuclear accumulation of histone deacetylase 4 (HDAC4) exerts neurotoxicity in models of Parkinson\u2019s disease. Mol. Neurobiol. 54, 6970\u20136983 (2017).","journal-title":"Mol. Neurobiol."},{"key":"2764_CR384","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02563-2","volume":"19","author":"Y Zhao","year":"2022","unstructured":"Zhao, Y. et al. Microglia-specific deletion of histone deacetylase 3 promotes inflammation resolution, white matter integrity, and functional recovery in a mouse model of traumatic brain injury. J. Neuroinflamm. 19, 201 (2022).","journal-title":"J. Neuroinflamm."},{"key":"2764_CR385","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cell.2013.10.004","volume":"155","author":"Y Cho","year":"2013","unstructured":"Cho, Y., Sloutsky, R., Naegle, K. M. & Cavalli, V. Injury-induced HDAC5 nuclear export is essential for axon regeneration. Cell 155, 894\u2013908 (2013).","journal-title":"Cell"},{"key":"2764_CR386","doi-asserted-by":"publisher","first-page":"19599","DOI":"10.1073\/pnas.0907935106","volume":"106","author":"MA Rivieccio","year":"2009","unstructured":"Rivieccio, M. A. et al. HDAC6 is a target for protection and regeneration following injury in the nervous system. Proc. Natl. Acad. Sci. USA 106, 19599\u201319604 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2764_CR387","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.phrs.2015.08.002","volume":"100","author":"S Sharma","year":"2015","unstructured":"Sharma, S. & Taliyan, R. Transcriptional dysregulation in Huntington\u2019s disease: The role of histone deacetylases. Pharm. Res. 100, 157\u2013169 (2015).","journal-title":"Pharm. Res."},{"key":"2764_CR388","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1474-4422(22)00121-1","volume":"21","author":"SJ Tabrizi","year":"2022","unstructured":"Tabrizi, S. J. et al. Potential disease-modifying therapies for Huntington\u2019s disease: lessons learned and future opportunities. Lancet Neurol. 21, 645\u2013658 (2022).","journal-title":"Lancet Neurol."},{"key":"2764_CR389","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1074\/mcp.RA118.001253","volume":"18","author":"JD Federspiel","year":"2019","unstructured":"Federspiel, J. D., Greco, T. M., Lum, K. K. & Cristea, I. M. Hdac4 interactions in Huntington\u2019s disease viewed through the prism of multiomics. Mol. Cell Proteom. 18, S92\u2013S113 (2019).","journal-title":"Mol. Cell Proteom."},{"key":"2764_CR390","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001717","volume":"11","author":"M Mielcarek","year":"2013","unstructured":"Mielcarek, M. et al. HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration. PLoS Biol. 11, e1001717 (2013).","journal-title":"PLoS Biol."},{"key":"2764_CR391","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1750-1326-8-7","volume":"8","author":"C Simoes-Pires","year":"2013","unstructured":"Simoes-Pires, C. et al. HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?. Mol. Neurodegener. 8, 7 (2013).","journal-title":"Mol. Neurodegener."},{"key":"2764_CR392","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156605","volume":"143","author":"M Guo","year":"2025","unstructured":"Guo, M. et al. Kirenol alleviates cerebral ischemic injury by promoting synaptic plasticity via HDAC2-mediated BDNF expression. Phytomedicine 143, 156605 (2025).","journal-title":"Phytomedicine"},{"key":"2764_CR393","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ng.1081","volume":"44","author":"International Stroke Genetics, C.","year":"2012","unstructured":"International Stroke Genetics, C. et al. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat. Genet 44, 328\u2013333 (2012).","journal-title":"Nat. Genet"},{"key":"2764_CR394","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.7150\/ijbs.80735","volume":"19","author":"L Sanguigno","year":"2023","unstructured":"Sanguigno, L. et al. Stroke by inducing HDAC9-dependent deacetylation of HIF-1 and Sp1, promotes TfR1 transcription and GPX4 reduction, thus determining ferroptotic neuronal death. Int J. Biol. Sci. 19, 2695\u20132710 (2023).","journal-title":"Int J. Biol. Sci."},{"key":"2764_CR395","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155599","volume":"129","author":"M Wang","year":"2024","unstructured":"Wang, M. et al. Ethanolic extract of Arctium lappa leaves alleviates cerebral ischemia reperfusion-induced inflammatory injury via HDAC9-mediated NF-kappaB pathway. Phytomedicine 129, 155599 (2024).","journal-title":"Phytomedicine"},{"key":"2764_CR396","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.freeradbiomed.2011.12.006","volume":"52","author":"B Wang","year":"2012","unstructured":"Wang, B. et al. Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage. Free Radic. Biol. Med 52, 928\u2013936 (2012).","journal-title":"Free Radic. Biol. Med"},{"key":"2764_CR397","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.expneurol.2015.07.026","volume":"273","author":"R Jagirdar","year":"2015","unstructured":"Jagirdar, R. et al. Rapid changes in expression of class I and IV histone deacetylases during epileptogenesis in mouse models of temporal lobe epilepsy. Exp. Neurol. 273, 92\u2013104 (2015).","journal-title":"Exp. Neurol."},{"key":"2764_CR398","doi-asserted-by":"publisher","first-page":"8422","DOI":"10.1523\/JNEUROSCI.22-19-08422.2002","volume":"22","author":"Y Huang","year":"2002","unstructured":"Huang, Y., Doherty, J. J. & Dingledine, R. Altered histone acetylation at glutamate receptor 2 and brain-derived neurotrophic factor genes is an early event triggered by status epilepticus. J. Neurosci. 22, 8422\u20138428 (2002).","journal-title":"J. Neurosci."},{"key":"2764_CR399","doi-asserted-by":"publisher","first-page":"S218","DOI":"10.1212\/WNL.47.6_Suppl_4.218S","volume":"47","author":"F Jerusalem","year":"1996","unstructured":"Jerusalem, F., Pohl, C., Karitzky, J. & Ries, F. ALS. Neurology 47, S218\u2013S220 (1996).","journal-title":"Neurology"},{"key":"2764_CR400","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ebiom.2019.01.038","volume":"40","author":"E Pigna","year":"2019","unstructured":"Pigna, E. et al. Histone deacetylase 4 protects from denervation and skeletal muscle atrophy in a murine model of amyotrophic lateral sclerosis. EBioMedicine 40, 717\u2013732 (2019).","journal-title":"EBioMedicine"},{"key":"2764_CR401","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1093\/brain\/awt164","volume":"136","author":"G Bruneteau","year":"2013","unstructured":"Bruneteau, G. et al. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression. Brain 136, 2359\u20132368 (2013).","journal-title":"Brain"},{"key":"2764_CR402","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.stemcr.2021.03.029","volume":"16","author":"K Stoklund Dittlau","year":"2021","unstructured":"Stoklund Dittlau, K. et al. Human motor units in microfluidic devices are impaired by FUS mutations and improved by HDAC6 inhibition. Stem Cell Rep. 16, 2213\u20132227 (2021).","journal-title":"Stem Cell Rep."},{"key":"2764_CR403","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2011.61","volume":"1","author":"B Tang","year":"2011","unstructured":"Tang, B., Dean, B. & Thomas, E. A. Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders. Transl. Psychiatry 1, e64 (2011).","journal-title":"Transl. Psychiatry"},{"key":"2764_CR404","doi-asserted-by":"publisher","first-page":"E4686","DOI":"10.1073\/pnas.1613842114","volume":"114","author":"S Bahari-Javan","year":"2017","unstructured":"Bahari-Javan, S. et al. HDAC1 links early life stress to schizophrenia-like phenotypes. Proc. Natl. Acad. Sci. USA 114, E4686\u2013E4694 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2764_CR405","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.2337\/dc25-S002","volume":"48","author":"American Diabetes Association Professional Practice, C.","year":"2025","unstructured":"American Diabetes Association Professional Practice, C. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025. Diab Care 48, S27\u2013S49 (2025).","journal-title":"Diab Care"},{"key":"2764_CR406","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbi.2014.02.001","volume":"213","author":"S Khan","year":"2014","unstructured":"Khan, S. & Jena, G. B. Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38\/ERK MAPK and apoptotic pathways: study in juvenile diabetic rat. Chem. Biol. Interact. 213, 1\u201312 (2014).","journal-title":"Chem. Biol. Interact."},{"key":"2764_CR407","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2019.110700","volume":"503","author":"DA Elgamal","year":"2020","unstructured":"Elgamal, D. A. et al. Ultrastructure characterization of pancreatic beta-cells is accompanied by modulatory effects of the HDAC inhibitor sodium butyrate on the PI3\/AKT insulin signaling pathway in juvenile diabetic rats. Mol. Cell Endocrinol. 503, 110700 (2020).","journal-title":"Mol. Cell Endocrinol."},{"key":"2764_CR408","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2119\/molmed.2010.00152","volume":"17","author":"EC Lewis","year":"2011","unstructured":"Lewis, E. C. et al. The oral histone deacetylase inhibitor ITF2357 reduces cytokines and protects islet beta cells in vivo and in vitro. Mol. Med 17, 369\u2013377 (2011).","journal-title":"Mol. Med"},{"key":"2764_CR409","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1007\/s00125-012-2615-0","volume":"55","author":"M Lundh","year":"2012","unstructured":"Lundh, M. et al. Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS-1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children. Diabetologia 55, 2421\u20132431 (2012).","journal-title":"Diabetologia"},{"key":"2764_CR410","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.mce.2016.09.006","volume":"439","author":"S Chriett","year":"2017","unstructured":"Chriett, S., Zerzaihi, O., Vidal, H. & Pirola, L. The histone deacetylase inhibitor sodium butyrate improves insulin signalling in palmitate-induced insulin resistance in L6 rat muscle cells through epigenetically-mediated up-regulation of Irs1. Mol. Cell Endocrinol. 439, 224\u2013232 (2017).","journal-title":"Mol. Cell Endocrinol."},{"key":"2764_CR411","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1172\/JCI85963","volume":"127","author":"H Qian","year":"2017","unstructured":"Qian, H. et al. HDAC6-mediated acetylation of lipid droplet-binding protein CIDEC regulates fat-induced lipid storage. J. Clin. Invest 127, 1353\u20131369 (2017).","journal-title":"J. Clin. Invest"},{"key":"2764_CR412","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s10020-022-00507-3","volume":"28","author":"A Kumar","year":"2022","unstructured":"Kumar, A. & Datta, M. H19 inhibition increases HDAC6 and regulates IRS1 levels and insulin signaling in the skeletal muscle during diabetes. Mol. Med 28, 81 (2022).","journal-title":"Mol. Med"},{"key":"2764_CR413","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1016\/j.celrep.2016.05.006","volume":"15","author":"L Ozcan","year":"2016","unstructured":"Ozcan, L. et al. Hepatocyte DACH1 is increased in obesity via nuclear exclusion of HDAC4 and promotes hepatic insulin resistance. Cell Rep. 15, 2214\u20132225 (2016).","journal-title":"Cell Rep."},{"key":"2764_CR414","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s00125-016-4113-2","volume":"60","author":"M Daneshpajooh","year":"2017","unstructured":"Daneshpajooh, M. et al. HDAC7 is overexpressed in human diabetic islets and impairs insulin secretion in rat islets and clonal beta cells. Diabetologia 60, 116\u2013125 (2017).","journal-title":"Diabetologia"},{"key":"2764_CR415","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/dom.12470","volume":"17","author":"M Lundh","year":"2015","unstructured":"Lundh, M., Galbo, T., Poulsen, S. S. & Mandrup-Poulsen, T. Histone deacetylase 3 inhibition improves glycaemia and insulin secretion in obese diabetic rats. Diab Obes. Metab. 17, 703\u2013707 (2015).","journal-title":"Diab Obes. Metab."},{"key":"2764_CR416","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107311","volume":"26","author":"S Sasaki","year":"2023","unstructured":"Sasaki, S. et al. Type 2 diabetes susceptibility gene GRK5 regulates physiological pancreatic beta-cell proliferation via phosphorylation of HDAC5. iScience 26, 107311 (2023).","journal-title":"iScience"},{"key":"2764_CR417","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41581-024-00827-z","volume":"20","author":"DH van Raalte","year":"2024","unstructured":"van Raalte, D. H. et al. Combination therapy for kidney disease in people with diabetes mellitus. Nat. Rev. Nephrol. 20, 433\u2013446 (2024).","journal-title":"Nat. Rev. Nephrol."},{"key":"2764_CR418","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03312-0","volume":"12","author":"Z Xu","year":"2021","unstructured":"Xu, Z. et al. METTL14-regulated PI3K\/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease. Cell Death Dis. 12, 32 (2021).","journal-title":"Cell Death Dis."},{"key":"2764_CR419","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.938391","volume":"13","author":"Q Hou","year":"2022","unstructured":"Hou, Q. et al. Inhibition of HDAC6 With CAY10603 ameliorates diabetic kidney disease by suppressing NLRP3 inflammasome. Front Pharm. 13, 938391 (2022).","journal-title":"Front Pharm."},{"key":"2764_CR420","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154700","volume":"112","author":"R Dong","year":"2023","unstructured":"Dong, R. et al. Rutin alleviates EndMT by restoring autophagy through inhibiting HDAC1 via PI3K\/AKT\/mTOR pathway in diabetic kidney disease. Phytomedicine 112, 154700 (2023).","journal-title":"Phytomedicine"},{"key":"2764_CR421","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1042\/CS20210470","volume":"136","author":"Z Zheng","year":"2022","unstructured":"Zheng, Z. et al. The HDAC2\/SP1\/miR-205 feedback loop contributes to tubular epithelial cell extracellular matrix production in diabetic kidney disease. Clin. Sci. (Lond.) 136, 223\u2013238 (2022).","journal-title":"Clin. Sci. (Lond.)"},{"key":"2764_CR422","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3803\/EnM.2021.1336","volume":"37","author":"X Ma","year":"2022","unstructured":"Ma, X. & Wang, Q. Short-chain fatty acids attenuate renal fibrosis and enhance autophagy of renal tubular cells in diabetic mice through the HDAC2\/ULK1 Axis. Endocrinol. Metab. (Seoul.) 37, 432\u2013443 (2022).","journal-title":"Endocrinol. Metab. (Seoul.)"},{"key":"2764_CR423","doi-asserted-by":"publisher","first-page":"176643","DOI":"10.1016\/j.ejphar.2024.176643","volume":"975","author":"RB Daude","year":"2024","unstructured":"Daude, R. B., Bhadane, R. & Shah, J. S. Alpha-cyperone mitigates renal ischemic injury via modulation of HDAC-2 expression in diabetes: Insights from molecular dynamics simulations and experimental evaluation. Eur. J. Pharm. 975, 176643 (2024).","journal-title":"Eur. J. Pharm."},{"key":"2764_CR424","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1016\/j.ajpath.2011.01.044","volume":"178","author":"A Advani","year":"2011","unstructured":"Advani, A. et al. Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism. Am. J. Pathol. 178, 2205\u20132214 (2011).","journal-title":"Am. J. Pathol."},{"key":"2764_CR425","doi-asserted-by":"publisher","first-page":"R127","DOI":"10.1530\/EJE-17-0724","volume":"178","author":"E Levelt","year":"2018","unstructured":"Levelt, E., Gulsin, G., Neubauer, S. & McCann, G. P. MECHANISMS IN ENDOCRINOLOGY: Diabetic cardiomyopathy: pathophysiology and potential metabolic interventions state of the art review. Eur. J. Endocrinol. 178, R127\u2013R139 (2018).","journal-title":"Eur. J. Endocrinol."},{"key":"2764_CR426","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12933-015-0262-8","volume":"14","author":"Y Chen","year":"2015","unstructured":"Chen, Y. et al. Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice. Cardiovasc Diabetol. 14, 99 (2015).","journal-title":"Cardiovasc Diabetol."},{"key":"2764_CR427","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/CIRCULATIONAHA.117.031942","volume":"140","author":"M Kronlage","year":"2019","unstructured":"Kronlage, M. et al. O-GlcNAcylation of histone deacetylase 4 protects the diabetic heart from failure. Circulation 140, 580\u2013594 (2019).","journal-title":"Circulation"},{"key":"2764_CR428","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.156108","volume":"164","author":"JS Kim","year":"2025","unstructured":"Kim, J. S. et al. HDAC6 mediates NLRP3 inflammasome activation in the pathogenesis of diabetic retinopathy. Metabolism 164, 156108 (2025).","journal-title":"Metabolism"},{"key":"2764_CR429","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1495-3","volume":"16","author":"Q Zhao","year":"2019","unstructured":"Zhao, Q. et al. HDAC3 inhibition prevents blood-brain barrier permeability through Nrf2 activation in type 2 diabetes male mice. J. Neuroinflamm. 16, 103 (2019).","journal-title":"J. Neuroinflamm."},{"key":"2764_CR430","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1007\/s10565-022-09713-5","volume":"39","author":"D Zhang","year":"2023","unstructured":"Zhang, D., Du, J., Yu, M. & Suo, L. Urine-derived stem cells-extracellular vesicles ameliorate diabetic osteoporosis through HDAC4\/HIF-1alpha\/VEGFA axis by delivering microRNA-26a-5p. Cell Biol. Toxicol. 39, 2243\u20132257 (2023).","journal-title":"Cell Biol. Toxicol."},{"key":"2764_CR431","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.3390\/biom10101466","volume":"10","author":"R Teena","year":"2020","unstructured":"Teena, R. et al. Gene expression profiling of multiple histone deacetylases (HDAC) and its correlation with NRF2-mediated redox regulation in the pathogenesis of diabetic foot ulcers. Biomolecules 10, 1466 (2020).","journal-title":"Biomolecules"},{"key":"2764_CR432","doi-asserted-by":"publisher","first-page":"Itc65","DOI":"10.7326\/AITC202405210","volume":"177","author":"AH Gilden","year":"2024","unstructured":"Gilden, A. H., Catenacci, V. A. & Taormina, J. M. Obesity. Ann. Intern Med 177, Itc65\u2013itc80 (2024).","journal-title":"Ann. Intern Med"},{"key":"2764_CR433","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s42255-021-00515-3","volume":"4","author":"I Cakir","year":"2022","unstructured":"Cakir, I. et al. Histone deacetylase 6 inhibition restores leptin sensitivity and reduces obesity. Nat. Metab. 4, 44\u201359 (2022).","journal-title":"Nat. Metab."},{"key":"2764_CR434","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.cmet.2024.02.007","volume":"36","author":"D Guan","year":"2024","unstructured":"Guan, D. et al. Central inhibition of HDAC6 re-sensitizes leptin signaling during obesity to induce profound weight loss. Cell Metab. 36, 857\u2013876.e810 (2024).","journal-title":"Cell Metab."},{"key":"2764_CR435","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116129","volume":"223","author":"V Pena-Leon","year":"2024","unstructured":"Pena-Leon, V. et al. Novel mechanisms involved in leptin sensitization in obesity. Biochem Pharm. 223, 116129 (2024).","journal-title":"Biochem Pharm."},{"key":"2764_CR436","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.3390\/nu11112704","volume":"11","author":"AG Izquierdo","year":"2019","unstructured":"Izquierdo, A. G., Crujeiras, A. B., Casanueva, F. F. & Carreira, M. C. Leptin, obesity, and leptin resistance: Where are we 25 years later? Nutrients 11, 2704 (2019).","journal-title":"Nutrients"},{"key":"2764_CR437","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1096\/fj.201701586R","volume":"33","author":"AD Lieber","year":"2019","unstructured":"Lieber, A. D. et al. Loss of HDAC6 alters gut microbiota and worsens obesity. FASEB J. 33, 1098\u20131109 (2019).","journal-title":"FASEB J."},{"key":"2764_CR438","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.cmet.2014.03.024","volume":"19","author":"B Luan","year":"2014","unstructured":"Luan, B. et al. Leptin-mediated increases in catecholamine signaling reduce adipose tissue inflammation via activation of macrophage HDAC4. Cell Metab. 19, 1058\u20131065 (2014).","journal-title":"Cell Metab."},{"key":"2764_CR439","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13180-8","volume":"10","author":"M Davalos-Salas","year":"2019","unstructured":"Davalos-Salas, M. et al. Deletion of intestinal Hdac3 remodels the lipidome of enterocytes and protects mice from diet-induced obesity. Nat. Commun. 10, 5291 (2019).","journal-title":"Nat. Commun."},{"key":"2764_CR440","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202300149","volume":"67","author":"H Yang","year":"2023","unstructured":"Yang, H. et al. Sulforaphane mitigates high-fat diet-induced obesity by enhancing mitochondrial biogenesis in skeletal muscle via the HDAC8-PGC1alpha axis. Mol. Nutr. Food Res. 67, e2300149 (2023).","journal-title":"Mol. Nutr. Food Res."},{"key":"2764_CR441","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3390\/biomedicines13020260","volume":"13","author":"J Yang","year":"2025","unstructured":"Yang, J. et al. Butyrate prevents obesity accompanied by HDAC9-mediated browning of white adipose tissue. Biomedicines 13, 260 (2025).","journal-title":"Biomedicines"},{"key":"2764_CR442","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10782","volume":"7","author":"DG Kabra","year":"2016","unstructured":"Kabra, D. G. et al. Hypothalamic leptin action is mediated by histone deacetylase 5. Nat. Commun. 7, 10782 (2016).","journal-title":"Nat. Commun."},{"key":"2764_CR443","doi-asserted-by":"publisher","first-page":"E39","DOI":"10.1152\/ajpendo.00267.2017","volume":"314","author":"HA Lee","year":"2018","unstructured":"Lee, H. A. et al. Histone deacetylase inhibition ameliorates hypertension and hyperglycemia in a model of Cushing\u2019s syndrome. Am. J. Physiol. Endocrinol. Metab. 314, E39\u2013E52 (2018).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2764_CR444","doi-asserted-by":"publisher","first-page":"7869","DOI":"10.3390\/ijms23147869","volume":"23","author":"A Susetyo","year":"2022","unstructured":"Susetyo, A. et al. Histone deacetylase 3 inhibitor alleviates cerebellar defects in perinatal hypothyroid mice by stimulating histone acetylation and transcription at thyroid hormone-responsive gene loci. Int. J. Mol. Sci. 23, 7869 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"2764_CR445","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.776","volume":"12","author":"Y Jung","year":"2022","unstructured":"Jung, Y. et al. Upregulation of SNAP25 by HDAC inhibition ameliorates Niemann-Pick Type C disease phenotypes via autophagy induction. Clin. Transl. Med 12, e776 (2022).","journal-title":"Clin. Transl. Med"},{"key":"2764_CR446","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1194\/jlr.M072140","volume":"58","author":"NH Pipalia","year":"2017","unstructured":"Pipalia, N. H. et al. Histone deacetylase inhibitors correct the cholesterol storage defect in most Niemann-Pick C1 mutant cells. J. Lipid Res. 58, 695\u2013708 (2017).","journal-title":"J. Lipid Res"},{"key":"2764_CR447","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1152\/physrev.00004.2015","volume":"95","author":"EW Bradley","year":"2015","unstructured":"Bradley, E. W. et al. Histone deacetylases in bone development and skeletal disorders. Physiol. Rev. 95, 1359\u20131381 (2015).","journal-title":"Physiol. Rev."},{"key":"2764_CR448","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","volume":"393","author":"DJ Hunter","year":"2019","unstructured":"Hunter, D. J. & Bierma-Zeinstra, S. Osteoarthritis. Lancet 393, 1745\u20131759 (2019).","journal-title":"Lancet"},{"key":"2764_CR449","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105752","volume":"75","author":"XD Gu","year":"2019","unstructured":"Gu, X. D. et al. Adenovirus-mediated transduction with histone Deacetylase 4 ameliorates disease progression in an osteoarthritis rat model. Int Immunopharmacol. 75, 105752 (2019).","journal-title":"Int Immunopharmacol."},{"key":"2764_CR450","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-021-04947-6","volume":"23","author":"X Gu","year":"2022","unstructured":"Gu, X. et al. HDAC4 mutant represses chondrocyte hypertrophy by locating in the nucleus and attenuates disease progression of posttraumatic osteoarthritis. BMC Musculoskelet. Disord. 23, 8 (2022).","journal-title":"BMC Musculoskelet. Disord."},{"key":"2764_CR451","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13075-020-02373-y","volume":"23","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. HDAC2 interacts with microRNA-503-5p to regulate SGK1 in osteoarthritis. Arthritis Res. Ther. 23, 78 (2021).","journal-title":"Arthritis Res. Ther."},{"key":"2764_CR452","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1016\/j.ajpath.2020.08.013","volume":"190","author":"Y Zheng","year":"2020","unstructured":"Zheng, Y. et al. Inhibition of histone deacetylase 6 by tubastatin A attenuates the progress of osteoarthritis via improving mitochondrial function. Am. J. Pathol. 190, 2376\u20132386 (2020).","journal-title":"Am. J. Pathol."},{"key":"2764_CR453","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/ard-2021-221269","volume":"82","author":"H Ohzono","year":"2023","unstructured":"Ohzono, H. et al. Targeting FoxO transcription factors with HDAC inhibitors for the treatment of osteoarthritis. Ann. Rheum. Dis. 82, 262\u2013271 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"2764_CR454","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC202401160","volume":"177","author":"KE Ensrud","year":"2024","unstructured":"Ensrud, K. E. & Crandall, C. J. Osteoporosis. Ann. Intern Med. 177, ITC1\u2013ITC16 (2024).","journal-title":"Ann. Intern Med."},{"key":"2764_CR455","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115264","volume":"206","author":"Y Shangguan","year":"2022","unstructured":"Shangguan, Y. et al. Positive programming of the GC-IGF1 axis mediates adult osteoporosis susceptibility in male offspring rats induced by prenatal dexamethasone exposure. Biochem Pharm. 206, 115264 (2022).","journal-title":"Biochem Pharm."},{"key":"2764_CR456","doi-asserted-by":"publisher","first-page":"105990","DOI":"10.1016\/j.phrs.2021.105990","volume":"175","author":"Z Wu","year":"2022","unstructured":"Wu, Z. et al. 11beta-Hydroxysteroid dehydrogenase 2: A key mediator of high susceptibility to osteoporosis in offspring after prenatal dexamethasone exposure. Pharm. Res. 175, 105990 (2022).","journal-title":"Pharm. Res"},{"key":"2764_CR457","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1111\/bph.15225","volume":"177","author":"H Xiao","year":"2020","unstructured":"Xiao, H. et al. The low-expression programming of 11beta-HSD2 mediates osteoporosis susceptibility induced by prenatal caffeine exposure in male offspring rats. Br. J. Pharm. 177, 4683\u20134700 (2020).","journal-title":"Br. J. Pharm."},{"key":"2764_CR458","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1172\/JCI39832","volume":"119","author":"H Li","year":"2009","unstructured":"Li, H. et al. A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J. Clin. Invest 119, 3666\u20133677 (2009).","journal-title":"J. Clin. Invest"},{"key":"2764_CR459","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01525-w","volume":"22","author":"X Peng","year":"2024","unstructured":"Peng, X. et al. Pan-histone deacetylase inhibitor vorinostat suppresses osteoclastic bone resorption through modulation of RANKL-evoked signaling and ameliorates ovariectomy-induced bone loss. Cell Commun. Signal 22, 160 (2024).","journal-title":"Cell Commun. Signal"},{"key":"2764_CR460","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan, D. et al. Duchenne muscular dystrophy. Nat. Rev. Dis. Prim. 7, 13 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"2764_CR461","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.molmed.2024.01.007","volume":"30","author":"C Mozzetta","year":"2024","unstructured":"Mozzetta, C., Sartorelli, V., Steinkuhler, C. & Puri, P. L. HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients. Trends Mol. Med 30, 278\u2013294 (2024).","journal-title":"Trends Mol. Med"},{"key":"2764_CR462","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S1474-4422(24)00036-X","volume":"23","author":"E Mercuri","year":"2024","unstructured":"Mercuri, E. et al. Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol. 23, 393\u2013403 (2024).","journal-title":"Lancet Neurol."},{"key":"2764_CR463","doi-asserted-by":"publisher","first-page":"16658","DOI":"10.1021\/acs.jmedchem.3c01236","volume":"66","author":"YS Raouf","year":"2023","unstructured":"Raouf, Y. S. et al. Discovery of YSR734: A covalent HDAC inhibitor with cellular activity in acute myeloid leukemia and duchenne muscular dystrophy. J. Med Chem. 66, 16658\u201316679 (2023).","journal-title":"J. Med Chem."},{"key":"2764_CR464","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105750","volume":"170","author":"M Spreafico","year":"2021","unstructured":"Spreafico, M. et al. Targeting HDAC8 to ameliorate skeletal muscle differentiation in Duchenne muscular dystrophy. Pharm. Res. 170, 105750 (2021).","journal-title":"Pharm. Res"},{"key":"2764_CR465","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/jcsm.12891","volume":"13","author":"A Renzini","year":"2022","unstructured":"Renzini, A. et al. Cytoplasmic HDAC4 regulates the membrane repair mechanism in Duchenne muscular dystrophy. J. Cachexia Sarcopenia Muscle 13, 1339\u20131359 (2022).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"2764_CR466","doi-asserted-by":"publisher","first-page":"105807","DOI":"10.1016\/j.phrs.2021.105807","volume":"172","author":"L Yin","year":"2021","unstructured":"Yin, L. et al. Skeletal muscle atrophy: From mechanisms to treatments. Pharm. Res 172, 105807 (2021).","journal-title":"Pharm. Res"},{"key":"2764_CR467","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167023","volume":"1870","author":"G Zheng","year":"2024","unstructured":"Zheng, G. et al. HDAC9 inhibition reduces skeletal muscle atrophy and enhances regeneration in mice with cigarette smoke-induced COPD. Biochim Biophys. Acta Mol. Basis Dis. 1870, 167023 (2024).","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"2764_CR468","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1074\/jbc.M114.600916","volume":"290","author":"F Ratti","year":"2015","unstructured":"Ratti, F. et al. Histone deacetylase 6 is a FoxO transcription factor-dependent effector in skeletal muscle atrophy. J. Biol. Chem. 290, 4215\u20134224 (2015).","journal-title":"J. Biol. Chem."},{"key":"2764_CR469","first-page":"1441","volume":"127","author":"AW Beharry","year":"2014","unstructured":"Beharry, A. W. et al. HDAC1 activates FoxO and is both sufficient and required for skeletal muscle atrophy. J. Cell Sci. 127, 1441\u20131453 (2014).","journal-title":"J. Cell Sci."},{"key":"2764_CR470","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.552","volume":"8","author":"T Ma","year":"2017","unstructured":"Ma, T. et al. Suppression of BMP-7 by histone deacetylase 2 promoted apoptosis of renal tubular epithelial cells in acute kidney injury. Cell Death Dis. 8, e3139 (2017).","journal-title":"Cell Death Dis."},{"key":"2764_CR471","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1147772","volume":"14","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. VPA improves ferroptosis in tubular epithelial cells after cisplatin-induced acute kidney injury. Front Pharm. 14, 1147772 (2023).","journal-title":"Front Pharm."},{"key":"2764_CR472","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1681\/ASN.2009070690","volume":"21","author":"HF Li","year":"2010","unstructured":"Li, H. F. et al. ATF3-mediated epigenetic regulation protects against acute kidney injury. J. Am. Soc. Nephrol. 21, 1003\u20131013 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"2764_CR473","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.kint.2017.02.023","volume":"92","author":"W Lin","year":"2017","unstructured":"Lin, W. et al. Klotho restoration via acetylation of Peroxisome Proliferation-Activated Receptor gamma reduces the progression of chronic kidney disease. Kidney Int. 92, 669\u2013679 (2017).","journal-title":"Kidney Int"},{"key":"2764_CR474","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1681\/ASN.2010111196","volume":"22","author":"K Van Beneden","year":"2011","unstructured":"Van Beneden, K. et al. Valproic acid attenuates proteinuria and kidney injury. J. Am. Soc. Nephrol. 22, 1863\u20131875 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"2764_CR475","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biochi.2014.12.015","volume":"110","author":"S Khan","year":"2015","unstructured":"Khan, S., Jena, G., Tikoo, K. & Kumar, V. Valproate attenuates the proteinuria, podocyte and renal injury by facilitating autophagy and inactivation of NF-kappaB\/iNOS signaling in diabetic rat. Biochimie 110, 1\u201316 (2015).","journal-title":"Biochimie"},{"key":"2764_CR476","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41418-020-00631-9","volume":"28","author":"F Chen","year":"2021","unstructured":"Chen, F. et al. Histone deacetylase 3 aberration inhibits Klotho transcription and promotes renal fibrosis. Cell Death Differ. 28, 1001\u20131012 (2021).","journal-title":"Cell Death Differ."},{"key":"2764_CR477","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1681\/ASN.2019070739","volume":"31","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Loss of Histone H3 K79 Methyltransferase Dot1l Facilitates Kidney Fibrosis by Upregulating Endothelin 1 through Histone Deacetylase 2. J. Am. Soc. Nephrol. 31, 337\u2013349 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"2764_CR478","doi-asserted-by":"publisher","first-page":"8249","DOI":"10.1096\/fj.201801067RR","volume":"33","author":"C Xiong","year":"2019","unstructured":"Xiong, C. et al. Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis. FASEB J. 33, 8249\u20138262 (2019).","journal-title":"FASEB J."},{"key":"2764_CR479","doi-asserted-by":"publisher","first-page":"7295","DOI":"10.1096\/fj.201903254R","volume":"34","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis. FASEB J. 34, 7295\u20137310 (2020).","journal-title":"FASEB J."},{"key":"2764_CR480","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.phrs.2019.02.011","volume":"142","author":"M Yang","year":"2019","unstructured":"Yang, M. et al. Inhibition of class I HDACs attenuates renal interstitial fibrosis in a murine model. Pharm. Res. 142, 192\u2013204 (2019).","journal-title":"Pharm. Res"},{"key":"2764_CR481","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1242\/dev.153353","volume":"144","author":"X Li","year":"2017","unstructured":"Li, X. et al. HDAC3 promotes meiotic apparatus assembly in mouse oocytes by modulating tubulin acetylation. Development 144, 3789\u20133797 (2017).","journal-title":"Development"},{"key":"2764_CR482","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.fertnstert.2011.10.023","volume":"97","author":"J Huang","year":"2012","unstructured":"Huang, J. et al. Insufficient histone-3 lysine-9 deacetylation in human oocytes matured in vitro is associated with aberrant meiosis. Fertil. Steril. 97, 178\u2013184 e173 (2012).","journal-title":"Fertil. Steril."},{"key":"2764_CR483","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3724\/abbs.2025036","volume":"57","author":"J Shi","year":"2025","unstructured":"Shi, J. et al. HDAC11 in ovarian granulosa cells coordinates LH in the maturation of oocytes in Tan sheep. Acta Biochim Biophys. Sin. (Shanghai) 57, 1660\u20131669 (2025).","journal-title":"Acta Biochim Biophys. Sin. (Shanghai)"},{"key":"2764_CR484","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1093\/nar\/gkh735","volume":"32","author":"S Laduron","year":"2004","unstructured":"Laduron, S. et al. MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription. Nucleic Acids Res. 32, 4340\u20134350 (2004).","journal-title":"Nucleic Acids Res"},{"key":"2764_CR485","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.1093\/nar\/gkab313","volume":"49","author":"H Yin","year":"2021","unstructured":"Yin, H. et al. HDAC3 controls male fertility through enzyme-independent transcriptional regulation at the meiotic exit of spermatogenesis. Nucleic Acids Res. 49, 5106\u20135123 (2021).","journal-title":"Nucleic Acids Res"},{"key":"2764_CR486","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022112012","volume":"41","author":"M Wang","year":"2022","unstructured":"Wang, M., Chen, Z. & Zhang, Y. CBP\/p300 and HDAC activities regulate H3K27 acetylation dynamics and zygotic genome activation in mouse preimplantation embryos. EMBO J. 41, e112012 (2022).","journal-title":"EMBO J."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02764-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02764-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02764-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:01:58Z","timestamp":1789426918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02764-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":486,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2764"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02764-8","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"381"}}